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The average lifetime cost of care for people with Multiple Sclerosis (PwMS) in the 
United States is approximately $2.2 million per person affected, and up to 80% of PwMS are 
unemployed within 10 years of disease onset. MS-related fatigue is a debilitating symptom 
experienced by around 90% of PwMS, it can significantly affect an individual’s functional 
quality of life by interfering with activities of daily living (ADLs), causing reduced work 
performance, and contributing to loss of employment. MS-related fatigue is an umbrella term 
that encompasses the individual’s perceptions of fatigue (perceived fatigue) and measurable 
deterioration in performance (fatigability). Perceived fatigue and fatigability interfere with the 
individual’s efficient performance of physical and cognitive tasks and both should be considered 
during the assessment and management of MS-related fatigue. What further makes MS-related 
fatigue complex is that not only the disease process itself can cause fatigue, but also other 
prevalent comorbidities likely contribute to fatigue in MS such as depression and sleep 
disturbances. Therefore, the approach undertaken in the current body of research was under the 
notion that a multidisciplinary approach would seem best to optimally assess fatigue in PwMS. 
Perceived fatigue in PwMS is measured using self-reported scales which are used 
extensively in the MS-related fatigue field of research. However, there have been recent 
concerns regarding the psychometric properties of commonly used perceived fatigue scales in 
PwMS. This is an issue as interpreting the findings of those previous studies is now somewhat 
difficult. The current study utilized a more psychometrically sound perceived fatigue scale that 
has been validated for use in PwMS, called the Neurological Fatigue Index (NFI-MS). What 
makes the NFI-MS a unique measure of perceived fatigue in PwMS is that to our knowledge, it 
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is the only perceived fatigue scale that includes two sleep components acknowledging the 
importance of considering sleep quality during the assessment of fatigue.  
Chapter 2 attempted to explore the relationship between the NFI-MS and measures of 
physical and cognitive fatigability. Previous evidence showed conflicting results regarding the 
relationship between perceived fatigue and fatigability, as some showed associations while 
others did not. Fatigability is distinguished from perceived fatigue by the concept of change, i.e., 
a measurable difference in the performance of a task over a period of time. We initially 
hypothesized that there are certain items on the NFI-MS that objectify the performance ability of 
the individual and therefore can be associated with fatigability. A total of 52 ambulatory 
participants took part in this cross-sectional design study. Physical fatigability was measured 
using percent change in meters walked on the Six Minute Walk Test and percent change in force 
exerted on a repetitive maximal hand grip test. Cognitive fatigability was measured by Response 
Speed Variability on the Continuous Performance Test. The fatigability measures utilized in this 
study have been previously utilized before and where further modified in both administration and 
scoring in the current study to better capture fatigability in our study sample. Perceived physical 
and cognitive fatigue were measured using the NFI-MS. Current perceptions of fatigue were 
examined immediately before and after performing the fatigability measures using a 1-item 
Visual Analogue Fatigue Scale.  
The results of Chapter 2 showed that cognitive fatigability was significantly associated 
with the NFI-MS physical domain and NFI-MS cognitive domain. However, physical fatigability 
was not associated with the NFI-MS. All participants demonstrated significantly higher 
perceptions of current fatigue after performing the physical and cognitive fatigability measures. 
The findings suggest that the NFI-MS appears to capture the cognitive aspect of MS-related 
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fatigue (meaning it captures both perceived cognitive fatigue and cognitive fatigability), but not 
the physical aspect (only captures perceived physical fatigue not physical fatigability), and the 
fatigability measures utilized were fatiguing to the participants which is a clinically important 
finding. We can conclude that both perceptions of fatigue and fatigability should be measured 
collectively for a comprehensive assessment of fatigue in PwMS. 
Next, because an extensive body of evidence demonstrated a strong relationship between 
perceived fatigue and self-reported sleep quality, but conflicting results regarding the association 
between perceived fatigue and objective sleep quality; we aimed in Chapter 3 to explore the 
relationship between the NFI-MS and self-reported and objective sleep quality measures which 
have never been explored before. All participants filled out the Pittsburgh Sleep Quality Index to 
asses sleep quality, and the Epworth Sleepiness Scale to assess daytime sleepiness. To 
objectively quantify sleep quality, the participants wore an actigraph device on their dominant 
wrist for one week after the assessment day. The results indicated that higher perceived fatigue is 
significantly associated with poorer self-reported sleep quality and excessive daytime sleepiness, 
but not with objective sleep quality.  
Our findings from Chapter 3 support previous research that showed higher perceived 
fatigue measured using other scales is associated with poorer self-reported sleep quality and 
daytime sleepiness. Regarding the lack of association between perceived fatigue and objective 
sleep quality, we argued that perhaps there is a limitation of actigraphy to accurately assess sleep 
in this sample, as evidence showed that the actigraph may overestimate sleep efficiency and total 
sleep time. Furthermore, actigraphy findings might be limited by wear time. Perhaps PwMS need 
to wear the actigraph for more than one week to accurately assess their sleep quality. A previous 
study that found significant associations between actigraphy and fatigue had the participants 
vi 
 
wear the actigraph for two weeks. Based on our findings we encourage a wider use of the NFI-
MS in clinical and research settings to assess and manage the role sleep quality has on perceived 
fatigue in the MS population.  
The relationship between sleep quality and fatigability has never been explored before. 
Due to the involvement of central nervous system dysfunction mechanisms of both MS-related 
fatigue and sleep disturbances, and due to the evidence that shows a relationship between 
perceived fatigue and poor sleep quality, we hypothesized that there would be an association 
between higher physical and cognitive fatigability and poor sleep quality in our study sample. 
The results of Chapter 4 showed that several components of the Pittsburgh Sleep Quality Index 
and several actigraph parameters were significantly associated with physical fatigability and 
cognitive fatigability. We provide the first body of evidence showing the relationship between 
poor sleep quality and fatigability in PwMS. Fatigability is an important construct of MS-related 
fatigue that is a common debilitating symptom in the MS population, and more emphasis should 
be put on considering the role of sleep quality on exacerbating MS-related fatigue. 
In summary, the work presented in this dissertation expands on the body of evidence 
showing the relationship between perceived fatigue, fatigability, and sleep quality in PwMS. Our 
experiments and findings are novel and significant through the use of the NFI-MS as a measure 
of perceived fatigue and through the assessment of the association between sleep quality and 
fatigability in PwMS. For a comprehensive and multidimensional assessment of MS-related 
fatigue, the measures used in this study can be easily administered in clinical and research 
settings. In addition, more emphasis should be put on considering the role of sleep quality on 
exacerbating MS-related fatigue in those with the mild-disease forms of MS. Around 70% of 
PwMS report some sort of a sleep disturbance, and up to 50% have a diagnosable sleep disorder. 
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Poor sleep quality in PwMS has been associated with a reduction in several quality of life 
indices, including physical function, psychological well-being, self-care, work ability, and 
interpersonal relationships. Clinicians and therapists may need to consider sleep assessment and 
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1.1. Specific aims and purpose of study 
People with multiple sclerosis (PwMS) often experience a variety of symptoms. Fatigue is 
the most common symptom in multiple sclerosis (MS) experienced by 75% to 92% of PwMS 
and is difficult to treat.1-3 Fatigue is considered one of the most debilitating symptoms of MS and 
can significantly affect an individual’s quality of life, interfering with activities of daily living 
(ADLs), causing reduced work performance and contributing to loss of employment.4-7 While the 
disease process itself can cause fatigue, other prevalent comorbidities likely contribute to fatigue 
in MS, including depression,8-11 sleep disorders,9,12-14 and cognitive impairments. Thus, MS-
related fatigue is a multidimensional phenomenon.9,15-17 Multiple self-reported scales are used to 
assess perceived fatigue in PwMS, but those scales are limited in their ability to adequately 
capture the multidimensional nature of fatigue.  
Another important dimension of fatigue is fatigability,18,19 which is defined as the magnitude 
of change in the performance of a physical or a cognitive task over a period of time.18,19  
Fatigability interferes with the individual’s everyday life, as it diminishes the individual’s ability 
to efficiently perform tasks that requires prolonged or effortful activity such as walking or 
engaging in a conversation.19,20 Perceived fatigue and fatigability are different constructs, but 
they are related and both lie under the umbrella term of MS-related fatigue.18,19 Hence, it is 
important to delineate the association between the two constructs.19  
Sleep quality is further an important factor to consider in the assessment of MS-related 
fatigue. Sleep disturbances are common in PwMS21,22 and are associated with an increase in the 
perception of fatigue by this population. 14,23 Improved sleep quality recently has been shown to 
be a relieving factor, and poor sleep quality as an aggravating factor of self-reported MS-related 
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fatigue.24 However, no studies as yet give evidence if and how sleep quality contributes to 
fatigability.  
The Neurological Fatigue Index (NFI-MS) was developed in 2010 based on a 
multidimensional definition of MS-related fatigue developed by Mills and Young in 2008,24 
specifically for use in PwMS.25 Also, the NFI-MS is the only known self-reported MS-related 
fatigue scale that has a sleep component. Hence, the NFI-MS may provide a more efficient 
measure of MS-related fatigue. However, the relationship between self-reported fatigue as 
measured using the NFI-MS, fatigability, and objective measures of sleep quality has not been 
studied. Another unknown to be delineated is the concordance if any between the NFI-MS and 
other commonly used MS-related fatigue scales.  
The main purpose of this study is to assess the relationship between perceived fatigue (also 
referred to as self-reported fatigue) using the NFI-MS, physical and cognitive fatigability, and 
sleep quality in PwMS. A secondary purpose of this study is to determine the level of 
agreement between the NFI-MS and other commonly used MS-related fatigue scales. 
Establishing and clarifying the relationship between the above factors as proposed in this study 
would serve as a basis to guide clinicians and researchers in their assessment and treatment of 
MS-related fatigue. The ultimate goal is better treatment for MS-related fatigue and a better 
quality of life for PwMS. 
Specific Aim 1: to determine the relationship between self-reported fatigue, physical and 
cognitive fatigability, and sleep in PwMS We hypothesize that physical fatigability (measured 
using the Six Minute Walk Test (6MWT) and grip strength percent change) will make a 
significant contribution in explaining the variability of perceived fatigue as reported on the NFI-
MS. We also hypothesize that cognitive fatigability (measured by the Continuous Performance 
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Test (CPT) response speed variability score) will make a significant contribution in explaining 
the variability on perceived fatigue as reported on the NFI-MS. We hypothesize that the sleep 
quality (measured by actigraphy and the Pittsburgh Sleep Quality Index) will make a significant 
contribution in explaining the variability on perceived fatigue as reported on the NFI-MS.  
Specific Aim 2: To determine the level of agreement between the NFI-MS and other 
commonly used fatigue scales. We hypothesize that the NFI- MS will have sufficient agreement 
with the Modified Fatigue Impact Scale (MFIS) and Visual Analogue Fatigue Scale (VAFS) 
using Bland–Altman graphical analysis. 
 
1.2. Overview of MS 
Multiple sclerosis (MS) is a neurodegenerative disease characterized by the destruction of 
myelin in the axons of the brain and spinal cord.26 Most common symptoms of MS include 
fatigue, progressive cognitive impairments, physical decline, and sleep disturbances.11,27,28 MS 
affects 1/1000 individuals in the United States.29 The average lifetime cost of care for PwMS in 
the united states is approximately $2.2 million per person affected, and the national annual cost 
is estimated to be over $6.8 billion.30 Furthermore, 50-80% of PwMS are unemployed within 10 
years of disease onset.31 MS is a particularly devastating disease due to the early onset of 
symptoms, affecting the quality of life of these individuals. 
 
1.3. Overview of MS-related fatigue 
Reported by 75% to 90% of PwMS,1-3 fatigue is the most common symptom experienced by 
PwMS. Around 40% of PwMS describe fatigue as their worst symptom.32,33 Fatigue has been 
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shown to be related to a poorer quality of life, unemployment, and reduced ADLs in the MS 
population.4,6,7,34  
MS-related fatigue (defined in section 1.4.) is an umbrella term that includes both perceived 
(self-reported) fatigue and fatigability.19 Fatigability is the magnitude of change in the 
performance of a physical or a cognitive task over a period of time19 (Discussed in sections 1.5 
and 1.6). Perception of fatigue and fatigability are interrelated, and together negatively affects 
the individual’s quality of life.20 Evidence suggests that other prevalent factors associated with 
MS including sleep disturbances,12 cognitive impairments,15 and depression8 also contribute to 
fatigue in PwMS.  
The etiology of MS-related fatigue is poorly understood and is classified as primary or 
secondary depending on the cause.19,35,36 Primary fatigue is caused by the disease itself through 
axonal loss and demyelination throughout the CNS.38 Secondary fatigue is caused by factors or 
symptoms that accompany MS, such as sleep disturbances12, depression8, environmental 
factors37, and medication use38 (Figure
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Figure 1. A diagram showing the interaction of contributing factors to MS-related fatigue  
      
Due to the complex and multifactorial nature of fatigue, a multidisciplinary approach would 
seem best to optimally manage fatigue in PwMS.39-42 A combination of pharmacological and/or 
non-pharmacological treatments are recommended in the fatigue management plan.12,39,41 
Medications such as Amantadine, Pemoline, and Modafinil are often used in an attempt to lessen 
fatigue and its effects in PwMS.39,41 Several studies have employed non-pharmacological 
interventions to manage MS-related fatigue. Such interventions include education such as to 
avoid extreme weather conditions like heat and humidity, addressing lifestyle factors like diet 
and exercise, learning strategies for energy conservation, and adapting to work and household 
environments.39,43-45 However, a recent review by Khan et al.39 showed that the effects of both 
pharmacological and non-pharmacological treatments of fatigue in the MS population vary 

















1.4. Development of a definition of MS-related fatigue  
While studies acknowledge the complexity, and multifactorial nature of MS-related fatigue, 
its clear definition has been lacking. Some of the current definitions for fatigue include the 
following:  “overwhelming sense of tiredness, lack of energy or feelings of exhaustion”;46 
”difficulty initiating or sustaining voluntary effort”;47 “feelings of physical tiredness and lack of 
energy distinct from sadness or weakness”.32 These definitions are incomplete and use simplified 
and unclear terms to describe the complex symptom of fatigue. Some of these definitions 
encompass the perceived nature of fatigue but neglect fatigability, such as “overwhelming sense 
of tiredness, lack of energy or feelings of exhaustion”. Another definition: “difficulty initiating or 
sustaining voluntary effort”, includes only the fatigability component. None of the definitions 
listed mention anything pertaining to sleep quality. A complex symptom like fatigue requires a 
clear and comprehensive definition. Due to the multifactorial nature of fatigue in MS, an 
accurate definition of fatigue is one that would include the different factors that contribute to 
fatigue such as sleep quality and the individual’s perception of fatigue as well as fatigability. 
In an attempt to develop a clearer medical definition of fatigue, Mills et al. (2008)24 
conducted a two phase study. The first phase was a qualitative phase. Forty individuals with MS 
underwent a semi-structured interview and were asked to simply explain the term “fatigue”. 
Themes were created out of these interviews, specific themes such as motor features, cognitive 
features, and sleep patterns. The motor features theme seeks to describe the physical component 
of MS-related fatigue, but the researches refer it to it as motor. For example, the participants, in 
general described fatigue as heaviness in their limbs that caused difficulty to sustain tasks like 
walking, worsening of coordination throughout the day, and, sometimes, speech difficulties. The 
participants described the cognitive theme as having difficulties concentrating on simple tasks 
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that became worse throughout the day, making mistakes when they were tired, and difficulty 
sustaining attention. Sleepiness and disrupted nocturnal sleep emerged as aggravating factors of 
perceived fatigue, while daytime sleep was seen as a relieving factor. The latter finding is 
important, as sleep has been found to be associated with MS-related fatigue in other studies 
(Refer to section 1.8.). 
The second phase of the study by Mills et al was a quantitative phase in which the 
researchers developed a self-report symptom inventory consisting of 46 questions from the 
emergent themes created in the first phase. The inventory was sent to over 1200 individual with 
MS. After analyzing the inventories, the researchers developed the following definition of MS-
related fatigue: “a reversible, motor and cognitive impairment with reduced motivation and 
desire to rest, either appearing spontaneously or brought on by mental or physical activity, 
humidity, acute infection and food ingestion. It is relieved by daytime sleep or rest without sleep. 
It can occur at any time but is usually worse in the afternoon. In MS, fatigue can be daily, has 
usually been present for years and has greater severity than any premorbid fatigue”. This 
definition provides a more comprehensive description of MS-related fatigue, focusing not only 
on perceived fatigue, but also on how disrupted sleep is an aggravating factor. The definition 
also includes fatigability as indicated by “brought on by mental or physical activity”.  
In the development of the above definition, sleep emerged as an important factor associated with 
perceived fatigue as reported by the MS participants, both as an aggravating factor (disturbed 
nocturnal sleep) and as a relieving factor (sleep or rest during the day).24 No other commonly 
used definition of MS-related fatigue includes a sleep component. Furthermore, the motor and 
cognitive features of the definition of MS-related fatigue by Mills et al. take into account both 
perceived physical and cognitive fatigue as well as physical and cognitive fatigability. This 
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explains why the self-reported NFI-MS was chosen as a primary measure of perceived fatigue in 
this study, because it was developed based on Mills et al. definition24. Furthermore, we believed 
that physical fatigability and cognitive fatigability measures might be well associated with the 
NFI-MS based on how the two constructs were considered during the development of the 
definition, as well as in the NFI-MS (the development of the NFI-MS is discussed in section 
1.9.) 
 
1.5. Perceived fatigue and fatigability 
In healthy people, fatigue usually comes after prolonged activity, is a predictable symptom, 
and is resolved by rest.19 However, MS-related fatigue is usually chronic, causes disability that 
interferes with activities of daily living, and is unpredictable.19 MS-related fatigue negatively 
affects the individual’s quality of life, interferes with physical and cognitive tasks, can occur 
every day, can be exacerbated by environmental factors, as is related to sleep quality.4-7  
Kluger et al19 recently introduced a unified terminology and taxonomy of fatigue.18,19 Their 
approach distinguishes between fatigue as experienced and described by the individual with MS 
and fatigue as objectively quantified. The former is termed perceived fatigue; the latter is called 
fatigability.19  
Perceived fatigue (or self-report fatigue) is reported by the individual as a lack of motivation 
and tiredness in performing physical and cognitive tasks and that interferes with activities of 
daily living.18,48 Perceived fatigue is measured in many clinical fatigue studies using self- 
reported scales.19,49,50 The self-reported fatigue scales can vary widely in how they measure 
perceived fatigue:19 They can measure perceived fatigue in different domains (physical and 
cognitive), momentary vs. chronic perceptions of fatigue, and the severity and impact of fatigue 
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on function and daily life activities.19,49,50 Most studies rely on the assessment of fatigue using 
self-report.49-51 It is true that the perception of the individual is important to consider, and this is 
why a self-report scale in needed. However, one of the issues that arise in assessing fatigue is 
that most of the self-report scales do not capture the multidimensional nature of MS-related 
fatigue. In addition, assessing the perceptions of fatigue together with objective measures might 
be more sufficient to capture the multidimensionality of fatigue.19,24  
Fatigability is the measure of change in the performance of physical or cognitive tasks over 
a period of time.18,19 Fatigability objectively quantifies how much fatigue impacts the 
performance of several daily activities over time physically and cognitively.19,20,52 Physical 
fatigability and cognitive fatigability are the two measurable domains of fatigability.18,20,52 
Physical fatigability is the measured change in the continuous performance of a prolonged 
physical task, such as repetitive or sustained movements and walking speed over a period of 
time. Cognitive fatigability is the change in the continuous performance of a prolonged cognitive 
task, such as ability to sustain the same efficient level of attention over time. Fatigability is 
distinguished from perceived fatigue by the concept of change, i.e., a measurable difference in 
the performance of a task over a period of time.53 Fatigability objectifies the individual’s 
perception of fatigue levels as a deterioration in performing activities, whether physical or 
cognitive.19,20 Therefore, fatigability and perceived fatigue can be related but different constructs.  
Development of the concept and classifications of fatigability is ongoing.52 The definition 
and domain specification for fatigability that are used in this proposed study were introduced 
recently by Kluger et al. and other researchers.18-20,52,53 Fatigability studies in PwMS have mostly 
looked at changes in hand grip strength across repetitive movements, change in walking speed 
across time, and changes in sustained attention over time.54-60 Some studies have failed to 
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associate perceived fatigue and fatigability,16,61,62 while others did show an association.54-57 We 
believe that previous studies failed to establish a relationship because fatigue and fatigability are 
poorly understood and because the self-reported fatigue scales might not accurately capture the 
perception of fatigue in relation to change in performing physical or cognitive activities.  
One of the main purposes of this study is to delineate the relationship between perceived 
fatigue, as measured using the self-reported NFI-MS, and fatigability as measured using change 
in performance on physical and cognitive tests. The physical and cognitive tests used in this 
study were modified in both administration and scoring to detect fatigability. This study explores 
the percent change scores in two physical tests, the six minute walk test (6MWT) and the grip 
strength dynamometer test. A change score was calculated between the number of meters walked 
by the participant during the last and the first minute on the 6MWT.  A change score was also 
calculated between the last and the first trial of maximal force exerted in (Kg) on the grip 
strength dynamometer test. These methods to measure physical fatigability have been used in 
prior studies and are associated with self-reported physical fatigue in PwMS.55,63 Change in 
response speed variability (RSV) over time is the main outcome criterion of cognitive fatigability 
in this study, using the computerized Continuous Performance Test (CPT), which measures 
sustained attention.64 Change in RSV has been utilized in a previous study and was found to be 
associated with perceived cognitive fatigue by PwMS.56  
 
1.6. Central and peripheral components of MS-related fatigue 
MS-related fatigue has central and peripheral physiologic components.18,19,47,65  Physiologically, 
central fatigue (refer to Figure 2) results from a reduced central drive from the motor cortex, 
axonal nerve impulse blockage in demyelinated neurons, loss of feedback centrally from the 
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muscle spindle afferents, disruption of non-motor pathways in the basal ganglia and the striato-
thalamo-cortical fibers, and poor coordination between the firing of central nervous system 
(CNS) motor units.18,47 Peripheral fatigue is the decline in excitation or the complete failure to 
excite muscles due to delayed conduction within the muscle itself, often due to changes in 
muscle tissue and deficits in the function of the neuromuscular junction.18,47,66 Several studies 
have proposed that both perceived fatigue and fatigability in PwMS are central in nature due to 
physiological alterations in the CNS from the disease process,9,19,47,67-69 although peripheral 
components may also contribute.18,66,67 For this study, we are only considering central fatigue as 
it appears to be the largest contributor to MS-related fatigue (discussed as a potential limitation 








                                                                                               
 
                 Figure 2. A diagram showing the components of MS-related fatigue 
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Neuroimaging studies70-73 have showed an association between perceived fatigue measures 
and dysfunction in several brain regions in PwMS. A study by Filippi et al.72 found a significant 
association between perceived fatigue and less cerebral activation in regions related to motor 
planning and cognition. A recent study by Wilting et al.73  showed that in persons with early 
stage (< 10 years since diagnosis), relapsing-remitting MS, perceived cognitive fatigue is 
associated with microstructural changes, including altered molecular motion and cellular 
alignment within the fiber tracts, in several brain regions, but mainly in the thalamus. Perceived 
fatigue in PwMS has also been found to be associated with lesions in the areas and pathways 
associated with the limbic system and the basal ganglia.47  
To our knowledge, no studies have yet been published that associate the fatigability 
measures utilized in the current study and specific brain regions or nerve fiber tracts in PwMS. 
However, a recent functional neuroimaging study showed that PwMS demonstrated a decline in 
the activation of cortical motor and non-motor regions during a sustained motor task compared to 
healthy controls, suggesting the involvement of central factors with physical fatigability.74 In 
addition, neuroimaging studies found higher RSV is associated with dysfunction of the fronto-
cortical networks and decreased white matter brain volume in other populations.75 Nerve 
stimulation and transcranial magnetic stimulation (TMS) studies in healthy people have shown 
an association between physical fatigability and alterations in the excitability of the motor cortex 
and spinal cord.76,77  Factors resulting in secondary fatigue, such as depression, have been shown 
to be associated with white matter brain lesions and dysfunctions in the temporal, frontal, and 
parietal areas, as well as in the limbic system.78,79     
 
1.7. Physical and cognitive fatigability 
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Fatigability was described and defined in section 1.5. In this section details of the two 
fatigability constructs are discussed: physical and cognitive fatigability.  
Physical fatigability is the reduced ability to complete sustained physical tasks, even in the 
absence of profound motor weakness.47,80 Physiologically, physical fatigability is due to a 
dysfunction in the CNS that leads to a decline in muscle activity.18,48,80,81 At the central level (in 
spinal cord), physical fatigability results from diminished coordination of spinal motor neurons, 
resulting in an increased feedback from muscle afferents, type 3 and 4 and loss of feedback from 
type 1 muscle spindles.81 Details on how physical fatigability is measured and how the current 
study advanced those measures is discussed previously in section 1.5.  
Cognitive fatigability is the reduced ability to efficiently sustain cognitive tasks, even when 
no profound cognitive dysfunction is present.47 It is described as the inability to sustain 
concentration and attention during demanding cognitive tasks like following conversations or 
calculating numbers, resulting in diminished mental flexibility and decreased planning 
ability.47,54,56,82 While there is no specific objective measure of cognitive fatigability, various 
cognitive tests have been proposed to detect cognitive fatigability, either by a different method of 
scoring or by repeated administration of tests.54,56,83,84   
A proposed method for detecting cognitive fatigability is testing for a change in response 
speed variability (RSV) over time on the Continuous Performance Test (CPT). Previous research 
has shown that high RSV or high reaction time variability (RTV), are associated with self-reports 
of cognitive fatigue in PwMS56 and in other like populations such as people with chronic fatigue 
syndrome.85 Research suggests that persons with high RSV exert less alertness and attention on a 
cognitive task than people with normal responses.56 Functional neuroimaging studies have shown 
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that response variability is associated with central factors such as disruptions in the thalamo-
cortical circuits and a decrease in white matter.75,86,87  
It is important to note that cognitive fatigue and cognitive fatigability are not that same as 
cognitive impairments.88 Perceived cognitive fatigue and cognitive fatigability can occur in the 
absence of a cognitive impairment. 68,69 An individual with MS can achieve a high performance 
on a cognitive task but at the same time report high cognitive fatigue and fatigability. Evidence 
suggests that in PwMS, cognitive fatigue and fatigability can result from physiologic 
compensation processes in the brain to achieve high performance in cognitive tests. As a result of 
those compensation processes PwMS tend to experience higher fatigue to achieve the same level 
of performance compared to their healthy counterparts73,89 The latter is supported by the finding 
that perceived cognitive fatigue is itself associated with pathways in the brain that mediate 
cognitive functions, specifically the striatal-thalamic-frontal network.90-92 On the other hand, 
cognitive fatigability can become worse in the presence of a cognitive impairment.88,93 More 
cognitively-impaired participants may develop cognitive fatigue more quickly or have higher 
cognitive fatigability, as they may require more time and effort to complete the tests.94   
When assessing for cognitive fatigue and cognitive fatigability, one must consider the 
cognitive state of each participant. Severe cognitive impairments may interfere with the testing 
of cognitive fatigability and could be a confounding factor rendering results inconclusive. For the 
purposes of this study, those with severe cognitive impairments were excluded from 
participating. 
 
1.8. Contribution of sleep to MS-related fatigue 
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Sleep problems in individuals with MS are very common. Approximately 50% of patients 
with MS have a diagnosable sleep disorder, and up to 67% report some sort of sleep 
disturbance.21,22,95-98 Sleep disturbances and sleep disorders in PwMS have been overlooked by 
clinicians and researchers for years, and it is believed that a high percentage of PwMS have an 
unknown and underdiagnosed sleep disorder.99-101 An article published by Attarian et al. in 
200999 emphasized the importance of sleep quality in PwMS. The amount of published research 
on sleep in the MS population since that article was published has been doubled that done in the 
previous two decades.102 
Sleep disturbances in PwMS are classified as either primary (caused by the disease itself), or 
secondary (caused by disease-accompanied factors such as pain, medication, anxiety, depression, 
and bladder problems).36,102-104 Common sleep disorders diagnosed in PwMS, include insomnia, 
central or obstructive sleep apnea (OSA), restless leg syndrome (RLS), rapid eye movement 
(REM) behavior disorder, and narcolepsy.21,105-107 Poor sleep quality has been associated with a 
reduction in several quality of life indices, including physical function, psychological well-being, 
self-care, work ability, and interpersonal relationships.11 Evidence shows that poor sleep quality 
is an independent predictor of reduced quality of life in PwMS.99,103  
Sleep quality is often measured subjectively using self-reported scales. The Pittsburgh Sleep 
Quality Index (PSQI) is most commonly used.108 The PSQI provides a global self-reported sleep 
quality measure of the individual’s sleeping habits over one month. The PSQI also provides 
separate scores for seven different sleep components: use of sleep medication, sleep duration, 
habitual sleep efficiency, day-time dysfunction, sleep latency, sleep disturbances, and sleep 
quality. A global score of more than 5 on the PSQI reflects poor sleep quality across all age 
groups.108 Another construct of sleep quality that is important to consider is daytime sleepiness. 
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A common self-reported scale used to measure daytime sleepiness is the Epworth Sleepiness 
Scale (ESS). 109 In the ESS the participants rate how likely they would doze off in eight different 
scenarios of daily activities. The eight ESS items use a 4-point Likert scale in which a higher 
score indicates higher daytime sleepiness. Both the PSQI and the ESS were used in this study as 
measures of self-reported sleep quality. 
To better characterize the individual’s sleeping habits, objective measures of sleep quality 
are needed.110 The “gold standard” objective measure of sleep quality is polysomnography 
(PSG).111 PSG provides a detailed overlook of the individual’s sleep quality and sleep stages, and 
is often used to diagnose sleep disorders such as OSA.112 Actigraphy113 is another objective 
measure used extensively in sleep research. Actigraphy uses a watch-like device, an 
accelerometer worn on the wrist to record the participant’s sleep/wake cycle and circadian 
rhythms over a specified time frame. The actigraph has advantages over the PSG in that it costs 
less, portable, and records data in the subject’s natural sleep environment over multiple nights in 
a row. In the current study the actigraph was used to measure sleep quality over seven 
consecutive nights. 
Evidence demonstrates that sleep disturbances are associated with an increase in perceived 
fatigue in the MS population.13,14,102,105,114-116 Those studies suggest that the presence of sleep 
disturbances causes excessive activation of the CNS which, in turn, exacerbates MS-related 
fatigue. The excessive activation of the CNS may result from recurrent sleep arousals, and 
central mechanisms such as lesions on the suprachiasmatic nucleus in the hypothalamus that 
regulates circadian rhythms.115,116 In addition, MS-related fatigue is mediated by an increase in 
the activity of pro-inflammatory cytokines in the cerebrospinal fluid,117-119 an increase in the 
activity of similar pro-inflammatory cytokines are also associated with sleep disturbances.118,120 
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Thus, MS-related fatigue is associated with an increased incidence of sleep disturbances in 
PwMS. A recent study by Veauthier et al.121 demonstrated that individuals with MS who were 
treated for sleep disorders had significantly lower perceived fatigue than those who did not 
receive treatment for their sleep disorders. In the current study, persons with diagnosed but 
untreated sleep disorders are not included in this study, since the presence of an untreated sleep 
disorder would be a confounding factor. A limitation of the current study is the inclusion of 
participants with undiagnosed sleep disorders (discussed as a potential limitation of study in 
chapter 5 section 5.3.3). 
Several studies have investigated the association between sleep quality and perceived fatigue 
in PwMS using either self-reported sleep quality measures like the PSQI and ESS13,102,105,114-
116,122,123 or objective measures like actigraphy.105,124-126 Using actigraphy, Attarian et al.105 
demonstrated that fatigued PwMS have more disturbed sleep wake cycles than those who are not 
fatigued. Furthermore, several studies13,14,127,128 showed a significant relationship between 
perceived fatigue and the presence of a sleep disorder, like narcolepsy, OSA, RLS, and REM 
sleep behavior disorders. These studies have also found that perceived fatigue is associated with 
an increased number of nocturnal arousals and decreased sleep efficiency.13,14,127,128 Strober et 
al.102 recently developed a model to predict fatigue in PwMS using variables that include sleep 
disturbances, disease duration, and depression. Sleep disturbance was the most significant 
predictor of fatigue in PwMS, accounting for 25% of the variance followed by depression. In 
summary, sleep disturbances clearly impact fatigue in people with MS.  
Most of the previously mentioned studies13,14,23,119 that showed a relationship between sleep 
disturbances and perceived fatigue used the Modified Fatigue Impact Scale (MFIS) as the 
measure of perceived fatigue. This research highlights the importance in assessing sleep in 
19 
 
conjunction with fatigue either by a self-report measure or by admission to a sleep lab or use of 
Actigraphy to objectively assess sleep. Therefore, we believe that  establishing a relationship 
between objective and self-reported sleep quality and perceived fatigue using the self-reported 
NFI-MS would provide support the NFI-MS is a more efficient way to explore the effects of 
sleep quality on perceived fatigue. As to our knowledge, the NFI-MS is the only validated scale 
that measures how sleep impacts fatigue in PwMS. 
 
1.9. Other contributing factors to MS-related fatigue 
The following section discuss the secondary factors that contribute to MS-related fatigue. 
Those factors are important to consider in both the assessment and management of MS-related 
fatigue. 
1.9.1. Depression  
Depression is very common in PwMS, affecting almost half of the MS population. 129,130 
Several studies have found an association between depression and fatigue and have shown that 
depression must be controlled for when assessing MS-related fatigue. 9-11 As fatigue can also be 
a symptom of depression,131 both may clinically overlap, especially in PwMS.10 Therefore, To 
the use of a depression scale that lacks fatigue-related questions has been recently recommended 
when attempting to measure depression in PwMS.9 The use of a depression scale with fatigue-
related questions may show a significant, but inaccurate correlation between depression and MS-
related fatigue, skewing study results and their interpretation.9 In this study, depression is 
controlled for as a covariate in the analysis. Depression was measured in this study by asking 
participants to complete the Beck Depression Inventory-Fast screen (BDI), 132 which lacks 
fatigue-related questions.  
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1.9.2. Other Factors: Disease severity, subtype, pain, anxiety   
Other factors may contribute to MS-related fatigue. Disease severity has been studied 
extensively in the MS-related fatigue research. However, results conflict regarding the 
association between disease severity and MS-related fatigue. Some studies have found a 
relationship between fatigue and disease severity as measured by the Expanded Disability Status 
Scale (EDSS),133-138 but other studies have not.78,139-141 Disease severity may be a possible 
confounding factor and is used as a covariate in the analysis in this study.  
MS subtype may contribute to MS-related fatigue. Fatigue has been associated with more severe 
forms of progressive MS.137,142 Pain has also been found to exacerbate fatigue in the MS 
population.133,139 Medication use is suggested as another contributing factor to MS-related 
fatigue.3,116,138,143,144 Poly-pharmacy, side effects of medications, like pain killers, and 
immunosuppressive therapies, particularly interferon- β use, increase fatigue in the MS 
population. Cognitive impairment is also suggested as a contributing factor.9,90-92 In addition, 
psychological factors, such as stress and anxiety, serve to increase fatigue in individuals with 
MS.145-147 In this study we gathered information regarding disease severity, MS type, medication 
us, and anxiety. Those with severe forms of MS, who cannot ambulate independently with or 
without an assistive device, were not included in this study. 
 
1.10. Commonly used perceived fatigue scales in MS 
Several self-report scales are used in research and clinical settings to assess perceived 
fatigue.49,50 The most commonly used fatigue scales are the Modified Fatigue Impact Scale 
(MFIS),148 the Fatigue Severity Scale (FSS),149 and the Visual Analogue Fatigue Scale 
(VAFS).150 Despite the fact that the Multiple Sclerosis Council for Clinical Practice Guidelines 
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advocated further psychometric evaluation of the MFIS to establish its validity,151 researchers 
continue to use the scale despite its lacking a proper psychometric evaluation.152 The MFIS148 
consists of twenty-one items divided into three components: physical, cognitive, and 
psychosocial. A higher score indicates a greater level of fatigue. The FSS149 consists of nine 
questions; and again, a higher score denotes more fatigue. Although the MFIS and FSS are 
commonly used scales, they have some disadvantages as well, as revealed by the Rasch model 
analysis. The VAFS150 is a single item scale; the individual marks a number that best rates 
his/her current perceived fatigue. The VAFS is considered very simple and easy to use, and, 
unlike the aforementioned scales, the VAFS measures current fatigue, i.e., how much the person 
is fatigued at the moment.  
The Rasch model analysis153,154 is a statistical analysis that uses a psychometric approach to 
develop and refine patient reported outcomes. The concept behind the Rasch model is that a 
participant’s response to items on a scale eventually produce linear measurements. In other 
words, the Rasch analysis is uni-dimensional; it measures both the participant’s ability to answer 
an item and the difficulty of that item under the same construct. For example, on an accurate 
fatigue scale, a person who’s highly fatigued would be able to distinguish and affirm items 
expressing high levels of fatigue.154,155  
The FSS does not fit the Rasch model.156 Certain items on the FSS interact, and their 
removal improves its psychometric properties and accuracy. In addition, evidence reveals how 
the FSS is not sensitive enough to capture the multidimensional nature of MS-related fatigue in 
studies using the scale as a main outcome measure.157,158  
The MFIS also does not fit the Rasch model.159 The different components of the scale, i.e., 
items on the cognitive subscale and items on the physical subscale interact and affect the scale’s 
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accuracy and the interpretation of its results. Specific items from the physical and cognitive 
components of the MFIS should be removed for the scale to fit the Rasch model. Also, the 
psychosocial component should be totally eliminated because it interacts with the physical 
component. Rasch analysis of the MFIS renders the total score of the MFIS invalid and thus 
compromises the findings of previous studies that used the scale’s total score. In addition, Larson 
et al. in 2013152 argue that future studies are needed to solve several other issues affecting the 
MFIS. For example, the MFIS fails to distinguish adequately between the different constructs of 
sleepiness/alertness and fatigue affecting the interpretation of results obtained by use of the 
MFIS.152  
The MFIS has been used to examine the associations between physical fatigability and 
perceived physical fatigue.55,57 Results vary between studies. When the change in walking speed 
is used as a measure of physical fatigability, an association between perceived physical fatigue as 
indicated on the MFIS and physical fatigability is established.55 But when change in grip strength 
is the criterion used to assess physical fatigability, researchers find no association between 
physical fatigability and perceived physical fatigue.57 Studies using the MFIS to measure 
cognitive fatigability also show conflicting results. 15,54,83,160 As there are no established objective 
measures of cognitive fatigue, previous studies attempted to use cognitive tests to quantify 
cognitive fatigability, mostly tests of information processing speed and attention have been 
used.15,54,83,160 However, we believe that its either because the MFIS does not accurately capture 
cognitive fatigability or perhaps the cognitive tests used in those studies are not specific in 
measuring cognitive fatigability, most of the attempts to associate perceived cognitive fatigue via 




1.11. Development of the NFI-MS 
This section provides an overview of the development of the NFI-MS highlighting the 
reasons for choosing the NFI-MS to assess perceived fatigue over commonly used scales for the 
current study.  
Mills et al.24 have developed a definition for MS-related fatigue (Section 1.4.). The same 
researchers have expanded their work following guidelines from the Food and Drug 
Administration (FDA)161 for developing outcome measures and the standards of the Rasch model 
analysis154 for developing patient reported outcomes. The FDA created specific guidelines161 for 
researchers in clinical trials that aim to develop new patient reported outcomes. Those guidelines 
include identifying both the specific domains to be measured and the population of interest, 
generation of adequate domains, and clearly stating the method of data collection.  
The Neurological Fatigue Index (NFI-MS)25 was developed in 2010 following the second 
quantitative phase of the effort by Mills et al. to define MS-related fatigue (Section 1.4.). After 
the collection of the 46 questions from the MS individuals, a draft scale was  developed by a 
multidisciplinary team of neurologists specialized in the treatment of MS, MS-specialized 
nurses, physical therapists, occupational therapists, rheumatologists, and a specialist in sleep 
medicine. To identify wording issues, the draft scale was sent to fifteen PwMS for their 
feedback. Revisions were made based on the feedback, and the revised draft scale was mailed to 
1223 PwMS to complete. Questions on demographics, disease information, and other fatigue 
scales (FSS, MFIS, VAFS) were also sent for completion to facilitate comparative analysis.  
The NFI-MS has been validated for use in PwMS using external construct validity and has 
been shown to have good test-retest reliability (more than 0.7 for all the scales) and a relatively 
small minimal clinically important difference (MCID).162 Less than 10% of scale range for all 
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components. These findings show that the NFI-MS scores accord with the participant’s 
perception of fatigue. The correlation analysis of each component with the other commonly used 
scales, the MFIS,FSS, and VAS evidences moderate to strong correlation, ranging from r= 0.4 to 
r= 0.7. Furthermore, the NFI-MS meets the standards of a fundamental outcome measure since 
the scale follows the Rasch model analysis, Thus, the NFI-MS is more suitable for parametric 
statistical tests than scales that do not fit the Rasch model25, such as the MFIS159 and the FSS.156  
In addition, the NFI-MS has certain items that seem to reflect both physical and cognitive 
fatigability: “The longer I do something the more difficult it becomes”; “My coordination gets 
worse as the day goes on”; “Mental effort really takes it out of me”. Statements such as these 
demonstrate a deterioration of performance on effortful physical and cognitive activities over 
time. The NFI-MS is the only perceived fatigue measurement tool that has a separate two sleep-
related component. The sleep components of the NFI-MS measure the effect of sleep on fatigue 
in two different aspects: relief of fatigue by diurnal sleep or rest, and exacerbation of fatigue due 
to abnormal nocturnal sleep and sleepiness. The NFI-MS is based on Mills et al.’s definition of 
MS-related fatigue24 (Section 1.4), and so outline the different aspects of sleep quality and their 
relation to perceived fatigue.  
In summary, the self-reported NFI-MS seems to capture the multidimensional aspects of 
perceived fatigue and also, as well as possible, fatigability by assessing physical, cognitive, and 
sleep-related contributions to perceived fatigue. 
1.12. Significance of this research 
Fatigue is the most common symptom in multiple sclerosis, experienced by up to 90% of 
MS patients, and is often difficult to treat.33,36,163 MS-related Fatigue negatively affects the 
quality of life of these individuals and has a profound economic impact as it is associated with a 
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reduced work load and high unemployment rates.5,7 Evidence shows that MS-related fatigue can 
lead to people with MS quitting their jobs and becoming home-bound which negatively impacts 
interpersonal relationships and income.164-167 Social interaction is also compromised due to 
fatigue leading to psychological distress, stress, and anxiety.6 Both perceived fatigue, fatigability, 
and disrupted sleep quality interfere with the performance of ADL such as simple house-hold 
activities, cause deterioration in the performance of effortful physical and cognitive tasks, and 
lead to the loss of function and the worsening of other symptoms.4,19,20,168  
Although a wide variety of self-reported scales of perceived MS-related fatigue are in use,169 
no consensus exists on the best clinically relevant, reliable, and responsive outcome 
measurement tool.36,170,171 In addition, no clearly established measure of fatigability exists, 
perhaps due to the poor understanding of how fatigability results and whether perceptions of 
fatigue are related to it or not. The latter explains why recent research acknowledges that 
establishing an association between fatigability and perceived fatigue has been difficult.19 
Whether perceived fatigue and fatigability are associated or not, considering both during the 
assessment and management of MS-related fatigue is crucial. In recent clinical research, a 
unified multidimensional approach to measure fatigue is recommended, so it seems that a better 
approach to measure MS-related fatigue includes both perceived fatigue and fatigability.19,20  
Considering sleep quality as part of the comprehensive assessment of MS-related fatigue 
also makes this study significant. Sleep disturbances affects almost 50% of PwMS,21,22,95 and 
there is extensive evidence that disturbed sleep is highly associated with increased perceived 
fatigue in the MS population.13,14,71-74   In addition, to our knowledge no previous study attempted 
to explore the relationship between sleep quality and fatigability. Recently there has been 
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recommendations encouraging the need to assess both sleep and fatigue in the MS population for 
more accurate sleep quality assessment and more affective fatigue management in PwMS.13,14,23  
To date, no study has collectively assessed physical fatigability, cognitive fatigability, and 
sleep quality objectively, and then attempted to explore the associations between these factors 
with perceived fatigue in the MS population.54,99,172 In the latter studies, perceived fatigue was 
measured using other scales like the FSS and the MFIS. The researchers who developed the NFI-
MS, Mills et al., have explored the relationship between perceived fatigue using the NFI-MS and 
other clinical features of MS.122 The researchers correlated the NFI-MS with subjective measures 
of depression, anxiety, motor function, and sleep quality. However, no fatigability measures of 
any component were used in the study. Also, sleep quality was quantified by self-estimation of 
the participants only; they estimated the duration of both nocturnal and diurnal sleep. A self-
report measure, such as a well-known standard self-reported scale, was not used, nor were 
objective measures of sleep. Our study seeks to remedy the limitations of the above studies and 
to further elucidate the relationship between sleep quality and MS-related fatigue. 
A more comprehensive assessment of MS-related fatigue will improve the ability of 
clinicians to determine the impact of interventions directed toward treating that fatigue. In 
addition, a better understanding of which specific factors significantly contribute to an 
individual’s fatigue would allow clinicians to more narrowly target treatments to those specific 
factors. Showing in this study that reduced sleep quality and the other factors of physical and 
cognitive fatigability are highly associated with perceived MS-related fatigue encourage the 
development and use of interventions to improve sleep quality, thereby reducing MS-related 
fatigue. Physical and cognitive training paradigms that increase both physical and cognitive 
stamina may be developed lessening MS-related fatigue. For example, studies that have assessed 
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the impact of exercise on fatigue have had mixed results. However more accurate outcome 
measures of fatigue may clarify the relationship.156-159,173  
Fatigability and sleep quality can be easily assessed in research and clinical settings using 
the modified measures employed in this study. Establishing and clarifying a relationship between 
perceived fatigue, fatigability, and sleep quality will foster the understanding of MS-related 
fatigue and will guide both researchers and clinicians to better and more accurately assess, 
measure, and eventually target treatments of MS-related fatigue. 
In summary, this study is significant because to our knowledge there has been no previous 
attempt to establish a multidimensional approach in measuring MS-related fatigue, using 
measures of perceived fatigue as measured using the NFI-MS, objective measurements of 
fatigability, and sleep quality. Establishing a comprehensive assessment of MS-related fatigue 
and understanding what factors contribute to this complex symptom, will eventually guide 
clinicians toward more effective treatments of MS-related fatigue. This would dramatically 
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Background: Perceived fatigue and fatigability are components of MS-related fatigue. 
Understanding the relationship between these two constructs could lead to more effective 
interventions to manage MS-related fatigue. However, the relationship between physical and 
cognitive perceptions of fatigue measured using the Neurological Fatigue Index (NFI-MS), 
which is a psychometrically accurate measure of perceived fatigue in people with multiple 
sclerosis (PwMS), and physical and cognitive fatigability in PwMS is unknown. Objective: To 
explore the relationship between the NFI-MS and physical and cognitive fatigability in PwMS. 
Methods: Fifty-two participants (mean age: 46.8 ± 10.1) completed the study. Physical 
fatigability was measured using percent change in meters walked on the 6MWT and percent 
change in force exerted on a repetitive maximal hand grip test. Cognitive fatigability was 
measured by Response Speed Variability (RSV) on the Continuous Performance Test (CPT). 
Perceived physical and cognitive fatigue were measured using the NFI-MS. Current perceptions 
of fatigue were examined immediately before and after performing the fatigability measures 
using a 1-item Visual Analogue Fatigue Scale (VAFS). Results: Cognitive fatigability was 
significantly associated with the NFI-MS physical domain (r= .326, p= .020), and NFI-MS 
cognitive domain (r = .276, p=.05). However, physical fatigability was not associated with the 
NFI-MS. Participants demonstrated significantly higher perceptions of current fatigue after 
performing the fatigability measures (p= ≤ .001). Conclusions: The NFI-MS and the fatigability 
measures utilized in this study are easy to administer. We encourage a wider use of those 






        Fatigue is the most debilitating symptom of Multiple Sclerosis (MS).1 It interferes with 
daily function, affects work load, and hampers interpersonal relationships, often leading to 
reduced quality of life.7 MS-related fatigue is multidimensional consisting of different 
components such as perceived physical and cognitive fatigue and fatigability,146 and results from 
disruptions in cortico-subcortical brain regions174 as well as due to other comorbidities, such as 
depression10 and cognitive impairments.9  
A recent study by Kluger et al.19 introduced a unified taxonomy to guide the assessment 
and management of fatigue in neurologic populations. The taxonomy distinguished between 
fatigue that is perceived by the individual, referred to as “perceived fatigue,” and fatigue that can 
be objectively quantified by the researcher or clinician, referred to as “fatigability.” Perceived 
fatigue in people with MS (PwMS) is defined as a lack of motivation and/or sense of tiredness 
that makes it difficult to efficiently perform daily physical and cognitive tasks.18,48  Perceived 
fatigue can be measured using a variety of self-report scales.19,49,50  These self-report measures  
differ widely in how they gauge perception of fatigue and measure perceived fatigue under 
different constructs, such as physical or cognitive, or as momentary vs. chronic.19,49,50  
Researchers frequently  use the Modified Fatigue Impact Scale (MFIS)151 to assess MS-related 
perceived fatigue.148 However, a recommendation from the Multiple Sclerosis Council for 
Clinical Practice Guidelines suggests that the MFIS needs further psychometric evaluation.152  
The MFIS does not fit into the Rasch model analysis,159 which uses a psychometric approach to 
develop and refine patient-reported outcomes, and renders the score of the MFIS invalid. This 
might partially explain the conflicting results in prior studies that attempted to explore the 
relationship between perceived fatigue assessed using MFIS and fatigability in PwMS.55,60  
31 
 
Fatigability is defined as a measure of change in the performance of a physical or a 
cognitive task over time18,19 and can be objectively quantified by the clinician or researcher. 
There is no established measures of fatigability, and research is ongoing in terms of the 
measurement and classifications of fatigability.52 Previous studies have attempted to measure 
fatigability in PwMS in two ways: physically, through changes in walking speed or repetitive 
maximal upper and lower limb contractions over time, and cognitively, through changes in 
cognition over a period of time.54-60,175 Perception of fatigue can be related to fatigability if items 
in the self-report measure objectify the individual’s perception of fatigue levels as a deterioration 
in performing physical or cognitive activities.19,20 Nevertheless, fatigability is generally 
distinguished from perceived fatigue by the concept of change (a measurable difference in the 
performance of a task over a period of time)53 and how it is measured (quantified by 
clinician/researcher vs. reported by patient).   
Mills et al. developed the Neurological Fatigue Index (NFI-MS) to assess perceived 
fatigue in PwMS.25 The NFI-MS fits the Rasch model analysis, was developed following 
guidelines from the Food and Drug Administration (FDA)161, and has good external validity 
compared to commonly used scales in MS (MFIS and the Fatigue Severity Scale (FSS)). This 
makes the NFI-MS more psychometrically sound than commonly used fatigue scales in 
measuring perceptions of fatigue in PwMS.  
The relationship between perceived fatigue assessed using the NFI-MS and physical and 
cognitive fatigability is unknown in PwMS. Therefore, the main aim of this study was to explore 
the relationship between perceived fatigue, as measured using the NFI-MS, and physical and 
cognitive fatigability in PwMS. Both perceived fatigue and fatigability interfere with the 
performance of household activities, can lead to deterioration in the performance of physical and 
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cognitive tasks, and can worsen other symptoms, such as depression, sleepiness, and attention 
related problems.4,19,20,168 Understanding the relationship between fatigability and perceived 
fatigue could lead to more effective interventions to address these constructs and may encourage 
a wider use of these measures in clinical and research settings. 
2.3. Methods 
This study was performed in accordance with the University of Kansas Medical Center’s 
(KUMC) Institutional Review Board. The inclusion criteria include: (1) 18-60 years of age, (2) 
relapsing remitting or secondary progressive176, (3) able to ambulate with or without an assistive 
device, and (4) score > 24 on the Mini Mental Status Exam (MMSE)177. The exclusion criteria 
include: (1) history of alcohol/drug abuse or nervous system disorder other than MS, (2) severe 
physical, neurological, or sensory impairments that would interfere significantly with testing, (3) 
developmental history of learning disability or attention-deficit/hyperactivity disorder, (4) 
relapse and/or corticosteroid use within four weeks of assessment, (5) known untreated sleep 
disorder (such as sleep apnea) (6) uncorrected vision loss that would interfere significantly with 
testing, (7) acute ischemic cardiovascular event or coronary artery bypass surgery less than 3 
months ago, and (8) uncontrolled blood pressure with medication (BP > 190/110mmHg). PwMS 
were recruited to participant in this study at the MS clinic located at KUMC and through 
personal referral from participants and physicians. Informed consent was obtained from all 
participants. 
Fifty-two participants completed the study procedures. Medical history, medication 
usage, and demographic characteristics were obtained from the participants. Prior to testing, 
participants were asked to refrain from taking medications other than what they typically take 
and consuming caffeine beyond their typical daily consumption. Participants were instructed to 
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refrain from exercise for 24 hours prior to testing. On the day of the assessment, participants first 
completed a battery of self-reported questionnaires and then the fatigability measures which were 
randomized in order. 
Perceived fatigue was measured using the NFI-MS.25 The NFI-MS25 is a validated scale 
for use with PwMS that assesses perceptions of fatigue during the past two weeks. It consists of 
23 questions, each on a Likert scale from 0-3, with higher score indicating more fatigue. The 
NFI-MS measures perceived fatigue under three domains: physical, cognitive, and sleep quality. 
It also consists of a summary scale that includes both the physical and cognitive domains. For the 
purposes of this study, only the physical domain, cognitive domain, and summary score were 
used in data analysis. A validated ordinal to interval transformation of the raw scores of the NFI-
MS that was developed by Mills et al. was used.25  
Physical fatigability was measured using the Six-Minute Walk Test (6MWT) and a grip 
strength test. The 6MWT is a frequently used measure of physical performance and 
endurance.178 It has been previously modified in administration and scoring to assess physical 
fatigability in PwMS.55,60,172,179 The version used in this study was utilized by Goldman et al.55 
Specifically, instructions regarding permitted rest and encouragement phrases were eliminated 
and instructions regarding speed were emphasized. The administration was further modified for 
the current study by eliminating reminders every minute of how much time was remaining, and 
the participants were not informed that they would be walking for six minutes. Participants were 
instructed to walk as fast and as safe as they could back and forth along a 15-meter path marked 
with tape in a hallway. A cone marked the turn-around at each end. The tape was marked with a 
red marker every one meter to ease calculating the distance walked. Participants were allowed to 
use their assistive device if they used one for community ambulation. During the test, the 
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administrator marked on the tape using a sticky tab where the participant was located at the end 
of every minute. Physical fatigability was calculated as a percent change in the distance walked 
between the first and the sixth minute.  
The second measure to assess physical fatigability was a grip strength test.  Grip strength 
is a frequently used method to measure hand grip strength180 and has been previously used to 
assess physical fatigability in PwMS by measuring change in grip force in kilograms (kg) 
through repetitive maximal hand grip over time.57,63,181 A JAMAR hydraulic hand-held 
dynamometer182 was used in this study; the handle was first adjusted according to the 
participant’s grip size.183 The participant was then instructed to sit upright, shoulder adducted to  
neutral, elbow flexed at 90 degrees, forearm and wrist in neutral position.184 Each participant was 
instructed to squeeze the hand-held dynamometer with maximum strength when the examiner 
said, “Squeeze now,” and continued to squeeze the handle maximally until the examiner said, 
“Stop.” Participants performed 15 trials of maximal hand grip contractions, holding each 
contraction for five seconds, with a five-second rest in between each repetition. The participants 
were not informed of the number of trials or the length of each trial. A metronome heard only by 
the examiner using a headset was used to maintain the 5 second intervals. The maximal force 
exerted for each trial was recorded. Physical fatigability was calculated by measuring the percent 
change between the first and last trial. The test was first administered using the dominant hand 
and then repeated using the non-dominant hand. Due to the recent evidence that demonstrate no 
significant difference in grip fatigability between dominant and non-dominant hands in PwMS,57 
data is only reported on the dominant hand in the current study.  
Cognitive fatigability was measured using the Continuous Performance Test (CPT) 
(Conners CPT 3™)64 which is a well-known computerized measure of sustained attention. 
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Participants were seated in front of a computer screen and instructed to press the space bar when 
any letter of the alphabet except the letter X appeared on the monitor. To assess fatigability, the 
test was modified by eliminating instructions that emphasize the participants to respond as fast as 
they can and participants were not informed how long the test lasted. The test takes 14 minutes to 
complete with no rest provided. Cognitive fatigability was measured using the Response Speed 
Variability (RSV) score, which was previously found to be effective in detecting cognitive 
fatigability in PwMS.56 The RSV measures the consistency of how fast the participant responds 
throughout the test. The mean RSV T-scores of the participants was used as the main outcome 
variable. 
Perception of current fatigue was assessed immediately preceding and following each 
fatigability measure using the 1 item-VAFS150. The participants were instructed to place a mark 
(X sign) on a 100 mm line indicating their current level of fatigue from “not at all fatigued” to 
“extremely fatigued.” The outcome measure was the value of the length in mm along the line 
where the participants placed the mark. 
Due to their associations with MS-related fatigue, depression, quality of life, functional 
status, and disease severity were also assessed using the Beck Depression Inventory (BDI-fast 
screen)185, the Multiple Sclerosis Quality of Life-54 Instrument (MSQOL),186 the Functional 
Status Questionnaire (FSQ),187 and the Patient Determined Disease Steps (PDDS) scale.188 
Data was analyzed using SPSS version 23 (IBM SPSS Statistics 23, ©IBM). Descriptive 
statistics were calculated for the demographics. Assumptions of normality were tested using the 
Shapiro-Wilk test and Normal Q-Q plots. When assumptions of normality were met, Pearson 
product correlations were utilized to examine the associations between perceived fatigue, 
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fatigability measures, and demographics. If the assumptions of normality were not met, 
Spearman product correlations were utilized. Wilcoxon Signed-Rank tests were used to examine 
the differences between the first minute and last minute on the 6MWT, between first trial and 
last trial on the grip strength test, and to examine differences in current fatigue measured using 
the 1-item VAFS from before to after each of the fatigability measures. Stepwise multivariate 
linear regression was utilized to examine which factors significantly predicts perceived fatigue in 
PwMS using the summary score of the NFI-MS as the dependent variable. Alpha level was set at 
0.05.  
2.4. Results 
A total of 52 participants with a mean age of 46.8 years old (± 10.1 SD) were included in the 
analysis. Refer to Table 1 for demographic information and clinical characteristics. Forty-four 
females and eight males participated, 47 with relapsing-remitting MS and five with secondary-
progressive MS. Participants presented mostly with mild disease (PDDS 1.8 ± 1.6), minimal to 
mild depression (BDI 3.7 ± 3.1), and no severe global cognitive impairments (MMSE 28.7 ± 
1.6).  
2.4.1. Change in performance on fatigability measures and current fatigue 
       Total meters walked on the 6MWT in the last minute (average 66.3 m ± 20.4) compared to 
the first minute (average 74.6 m ± 18.2) decreased by 12.7%. The total force in kg exerted in the 
last trial in the grip strength test (average 16.1 kg ± 6.2) compared to the first trial (average 24.9 
kg ± 8.4) decreased by 35.9%. Figure 1 illustrates performance at every minute on the 6MWT 
and during each trial on the grip test of the dominant hand. Meters walked in the sixth minute 
were significantly lower than those walked in the first minute in the 6MWT (Z= -6.130, p= ≤ 
.001). The force exerted at trial 15 was significantly lower than the force exerted in the first trial 
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in the grip strength test of the dominant hand (Z= -6.303, p= ≤ .001). Current perceived fatigue 
was significantly higher following performance of each fatigability measures compared to 
current perceived fatigue measured before performing the measures (Grip strength test: Z= -
5.691, p= ≤ .001, 6MWT: Z= -5.906, p= ≤ .001, CPT: Z= -6.150, p= ≤ .001; Figure 2).  
2.4.2. NFI-MS and fatigability 
The percent change score of the 6MWT was not significantly associated with the NFI-
MS physical domain (r=-.119, p= .409), cognitive domain (r=.072, p=.620) or summary score (r= 
-.092, p=.523). The grip strength test change scores for the dominant hand were not significantly 
associated with the NFI-MS physical domain (r= .063, p= .661), cognitive domain (r= .082, p= 
.566), or summary score (r= .066, p= .646). In contrast, cognitive fatigability was significantly 
associated with the NFI-MS physical domain (r= .326, p= .020; Figure 3-A), NFI-MS cognitive 
domain (r = .276, p=.05-B), summary score (and r= .336, p= .016; Figure 3-C). The bivariate 
correlations analyses between the NFI-MS and the fatigability measures are shown in Table 2. 
2.4.3 NFI-MS and clinical characteristics 
       Depression was significantly associated with the NFI-MS domains (physical: r=.426, p= 
.002, cognitive: r=.458, p= .001) and summary score (r=.470, p= ≤ .001). Disease severity was 
also significantly associated with the NFI-MS domains (physical: r=.571, p= ≤ .001, cognitive: 
r=.442, p= .001) and the summary score (r=.546, p= ≤ .001). Further correlation analysis 
indicated that the NFI-MS domains were significantly and strongly associated with subjective 
functional status as measured using the FSQ (physical domain r= -.541, p= ≤ .001; cognitive 
domain r= -.516, p= ≤ .001; summary score r= -.575, p= ≤ .001). Mental quality of life as 
measured using the MSQOL was significantly and negatively associated with the NFI-MS 
domains (physical r= -.452, p= .001; cognitive r= -.530, p= ≤ .001; summary score r= -.488, p= ≤ 
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.001). Physical quality of life as measured using the MSQOL was also significantly and 
negatively associated with the NFI-MS domains (physical r= -.700, p= ≤ .001; cognitive r= -
.624, p= ≤ .001; summary score r= -.677, p= ≤ .001). Age and disease duration were not 
significantly associated with either the physical or cognitive domain or the summary score of the 
NFI-MS. Table 3 displays the bivariate correlations analysis between the NFI-MS scales and the 
clinical characteristics.   
2.4.4. NFI-MS regression analysis 
      Variables that were significantly associated with the NFI-MS summary score (PDDS, FSQ, 
BDI, physical and mental MSQOL, and RSV) were included in the regression model. The 
analysis retained only physical quality of life as a significant predictor of perceived fatigue, 
explaining 45.8% of the variance in the NFI-MS summary scale (R²= .458, p= ≤ .001). Due to 
the confounding effect of depression on fatigue, in which fatigue can be a symptom of 
depression or vice versa10; the regression analysis was repeated including the BDI score as a 
covariate. After controlling for depression, the physical quality of life remained a significant 
predictor explaining 34.3% of the variance in the NFI-MS summary scale (β = -.586, R²= .343, 
p= ≤ .001).  
2.5. Discussion 
       This is the first study to explore the relationship between perceived fatigue assessed using 
the NFI-MS and physical and cognitive fatigability in PwMS. The findings of this study indicate 
that higher cognitive fatigability is associated with higher perceptions of physical and cognitive 
perceived fatigue and overall perceived fatigue. Interestingly, physical fatigability was not 
associated with perceived physical fatigue, perceived cognitive fatigue, or overall perceived 
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fatigue. Another important finding is the strong significant association between physical quality 
of life and overall perceived fatigue in the study sample even after controlling for depression. 
Cognitive fatigability was significantly associated with perceived physical fatigue, 
perceived cognitive fatigue, and overall perceived fatigue. Only one previous study56 also used 
the RSV as a measure of cognitive fatigability, and they too found an association between 
cognitive fatigability and perceived cognitive fatigue measured using the Fatigue Impact Scale 
(FIS). Surprisingly, cognitive fatigability was associated with perceived physical fatigue in the 
current study. Perhaps the nature of the CPT (in which participants sat continuously for 14 
minutes without rest and used their finger to tap on the space bar continuously) contributed to the 
association with perceived physical fatigue. Furthermore, functional neuroimaging studies found 
that response variability was associated with central factors such as disruptions in the thalamo-
cortical circuits and decreased white matter volume,75,86,87  which might explain the involvement 
of physical perceptions of fatigue.  
         Interestingly, physical fatigability was not associated with perceived physical fatigue, 
perceived cognitive fatigue, or overall perceived fatigue. This lack of association is supported by 
prior studies that also failed to find an association between these constructs,57,60 but other studies 
have found an association between perceived physical fatigue and physical fatigability.55,58 The 
conflicting results may be due to different scoring and administration methods to calculate 
physical fatigability.55,60 Similar to the results of the current study, Leone et al.60 found no 
association between physical fatigability (measured using  6MWT percent change scores) and 
perceived fatigue (measured using the MFIS). However, Goldman et al.55 found that higher 
perceived physical fatigue (measured using the MFIS) was associated with lower meters walked 
on the 6MWT. Although the latter study recorded meters walked every minute, their main 
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outcome measure used in the analysis was total meters walked, not percent change as the current 
study and Leone et al. utilized.60 Severijns et al.57 found that perceived fatigue (measured using 
the MFIS) was not associated with grip fatigability in PwMS, which is consistent with the 
current study findings. However, a recent study by Wolkorte et al.58 found that perceived 
physical fatigue measured by the MFIS was weakly associated with index finger muscle 
fatigability measured using a force transducer. Due to the variability in methods to assess 
physical fatigability and perceived fatigue in PwMS, future studies should establish a valid 
measure of physical fatigability in PwMS and expand the use of the NFI-MS as a measure of 
perceived fatigue in research and clinical settings. 
MS-related fatigue is an umbrella term that encompasses both perceived fatigue and 
fatigability. Therefore, based on the findings of the current study, it appears that the NFI-MS 
captures the cognitive aspect of MS-related fatigue (meaning it captures both perceived cognitive 
fatigue and cognitive fatigability), but not the physical aspect (only captures perceived physical 
fatigue not physical fatigability). Larger scale studies are needed to verify these conclusions. One 
possible explanation is that perhaps the items on the NFI-MS physical domain are not worded in 
a manner that objectifies the individual’s performance physical fatigability, hence the lack of 
association. However, items on the NFI-MS cognitive domain such as “My coordination gets 
worse as the day goes on” and “Mental effort really takes it out of me” are worded in a manner 
that captures both perceptions of cognitive fatigue and cognitive fatigability. In addition, the 
confounding effect of peripheral fatigue might be another reason for the lack of association with 
perceived physical fatigue,18,67 which is the decline or complete failure to excite muscles often 
due to changes in muscle tissue or deficits in the function of the neuromuscular junction.18,47 
Although several studies have proposed that both perceived fatigue and fatigability in PwMS are 
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due to disease caused physiological alterations in the central nervous system,9,19,47,67 peripheral 
components may also contribute.18,67 Therefore, perhaps in order to capture the physical aspect 
of MS-related fatigue, both perceived physical fatigue measures and physical fatigability 
measures are needed collectively to capture the peripheral and central components of physical 
MS-related fatigue. Future studies with adequate sample size are needed to confirm these 
conclusions.  
Interestingly, most of the variability of perceived fatigue was explained by lower physical 
quality of life in this study sample even after controlling for the confounding effect of 
depression. This is an important finding that affirms the serious effects perceived fatigue has on 
the physical quality of life in PwMS. Only one previous study explored the relationship between 
perceived fatigue assessed using NFI-MS and MS-related clinical characteristics.122 The lack of 
association between perceived fatigue and age and disease duration is similar to those of Mills et 
al.,122 who observed no associations between perceived fatigue and age or disease duration, but 
found strong association with disease severity.  Mills et al found higher perceived fatigue was 
associated with a higher physical and psychological impact of MS measured using the Multiple 
Sclerosis Impact Scale (MSIS-29)122, which is somewhat similar to our finding in which reduced 
physical quality of life is associated with higher perceived fatigue in PwMS. Our study findings 
differ from Mills et al. in we found that depression was strongly associated with perceived 
fatigue, in contrast to the weak association found in their study. However, several previous 
studies found significant associations between depression and perceived fatigue in PwMS.9-11  
This might be due to the clinical overlap between depression and fatigue10 as fatigue can be a 
symptom of depression and vice versa. 
42 
 
The finding that current perceptions of fatigue increased significantly after performing 
the fatigability tests in a sample of individuals with mild disease severity is relevant for daily 
life. The fatigability measures used in this study resemble activities of daily living, and the 
finding that the those tasks where fatiguing the participants reflects how an individual with MS 
might be struggling functionally on a daily basis. The 6MWT is a walking task that resembles 
daily activities such as community ambulation. A strong, sustained grip is often needed to carry 
groceries or shopping bags. Sustained attention (CPT) is necessary for individuals to effectively 
perform continuous and repetitive activities, such as following clinician or therapist instructions. 
Being fatigued may affect the performance of these tasks and limit the individual’s functional 
abilities. Therapists and clinicians may need to consider structuring their interventions to limit 
increasing MS-related fatigue. For example, Karpatkin et al.179 suggested that PwMS might 
exhibit less perceived fatigue if they walk intermittently instead of continuously. This study 
showed that PwMS who walked intermittently for six minutes (walked every two minutes and 
rested another two minutes), had less perceived fatigue and walked more distances compared to 
those who continuously walked for six minutes.  
There are some limitations to the current study. First the cross-sectional design of the 
study makes it difficult to interpret the associations into a cause-effect relationship. In addition, 
our study findings are not generalizable to individuals with MS with moderate to severe disease 
severity, as the study sample on average had mild disease severity. Participants were permitted to 
take their usual medications the day of testing, which might have affected their performance on 
the tests. Furthermore, results should be interpreted with caution as due to the exploratory nature 





        In summary, perceived fatigue is associated with cognitive fatigability but not with physical 
fatigability in PwMS, and decreased physical quality of life is a large contributor to perceived 
fatigue in PwMS with mild disease severity. Due to the exploratory nature of the current study, 
larger scale future studies are needed to verify these findings and to explore the association 

















Table 1. Demographics and clinical characteristics of the participants.  
Gender Age MS Type 
Disease 



























Data is reported as mean (standard deviation). RR: Relapsing Remitting MS, SP: Secondary 
Progressive MS, PDDS: Patient Determined Disease Steps, MMSE: Mini Mental Status Exam, 
BDI: Beck Depression Inventory, FSQ: Functional Status Questionnaire, MSQOL: Multiple 
Sclerosis Quality Of Life. 





Data is reported as correlation co-efficient r (p-value). * Correlation is statistically significant at 
an alpha level ≤ 0.05. NFI-MS: Neurological Fatigue Index, 6MWT: Six Minute Walk Test, 



















































































Data is reported as correlation co-efficient r (p-value). *Correlation is statistically significant at 
an alpha level ≤ 0.05. NFI-MS: Neurological Fatigue Index, PDDS: Patient Determined Disease 
Steps, BDI: Beck Depression Inventory, FSQ: Functional Status Questionnaire, MSQOL: 









2.8. Figure Legends 
Figure 1. Physical fatigability for both the 6MWT and grip strength tests. (A) Meters walked 
every minute for a total of six minutes on the 6MWT. (B) Force exerted every trial for a total of 
15 trials on the grip strength test. 6MWT: Six Minute Walk Test. 
Figure 2. The difference in current perceived fatigue (VAFS) pre and post performing the 
fatigability measures. ***Difference is significant at an alpha level ≤ 0.001. 6MWT: Six Minute 
Walk Test, CPT: Continuous Performance Test. 
Figure 3. Scatter plots of cognitive fatigability (RSV) and the (A) physical, (B) cognitive, and 



















































The relationship between sleep quality and perceived fatigue measured using the Neurological 
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Objectives: The Neurological Fatigue Index (NFI-MS) is the only known perceived fatigue scale 
to include questions that consider the contribution of sleep quality to symptoms of fatigue in 
people with multiple sclerosis (PwMS). However, the relationship between the NFI-MS and 
sleep quality measures is unknown. This study aimed to explore the relationship between the 
NFI-MS and self-reported and objective sleep quality. Understanding the relationship between 
the NFI-MS and sleep quality measures could encourage a wider use of the NFI-MS in research 
and clinical settings. Methods: Fifty-one participants took part in this cross-sectional study 
(mean age: 47 ± 10.1 years old). Participants completed the NFI-MS to assess perceived fatigue, 
the Pittsburgh Sleep Quality Index (PSQI) to asses sleep quality, and the Epworth Sleepiness 
Scale (ESS) to assess daytime sleepiness. The participants wore an actigraph device one week on 
the dominant wrist to objectively quantify sleep quality. Results: Higher perceived fatigue is 
significantly associated with poorer self-reported sleep quality and excessive daytime sleepiness, 
but not with objective sleeps quality. Discussion: The NFI-MS can be administered in clinical 










Multiple sclerosis (MS) is a progressive neurological disease characterized by the 
destruction of the myelin sheath that covers and protects the axons of the brain and spinal cord.26 
The most common symptoms of MS include fatigue, cognitive impairments, physical decline, 
and sleep disturbances.11,27,28 MS affects 1/1000 individuals in the United States,29 and the 
average national annual cost of care for people with MS (PwMS) is estimated to be over $6.8 
billion.30 Furthermore, 50-80% of PwMS are unemployed within 10 years of disease onset. MS 
is a particularly devastating disease due to the early onset of symptoms, affecting the quality of 
life of these individuals.31 
MS-related fatigue affects up to 90% of PwMS and is often described as being the most 
severe symptom.1,33 Fatigue has been shown to be a major cause of unemployment and reduced 
function in the MS population.4,6,7,34 Self-report scales are widely used in research and clinical 
settings to assess the individual’s perception of fatigue, often referred to as “perceived 
fatigue.”49,50 Evidence suggests that perceived fatigue in the MS population is multifactorial, 
meaning that other prevalent factors associated with MS, including sleep disturbances,12 
cognitive impairments,15 and depression,8 contribute to perceived fatigue in PwMS. Due to this 
complexity, a comprehensive approach that takes into account the other associated factors in MS 
is recommended for both the assessment and management of perceived fatigue in the MS 
population.13 
Sleep problems in individuals with MS are very common. Approximately 50% of patients 
with MS have a diagnosable sleep disorder, and up to 67% report a sleep disturbance.96-98 
Evidence shows that poor sleep quality is an independent predictor of reduced quality of life99,103 
and has been associated with a reduction in several quality of life indices, including physical 
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function, psychological well-being, work ability, and interpersonal relationships.11 Sleep quality 
can be measured subjectively using self-report scales108 or objectively using polysomnography 
(PSG)111 or actigraphy.113 
Sleep disturbances have been shown to be associated with an increase in perceived fatigue in 
PwMS.13,14,102,105,107,114,116,189 Evidence suggests that the presence of a sleep disorder or poor 
sleep quality contributes to excessive activation of the central nervous system (CNS) which, in 
turn, exacerbates MS-related fatigue.116 Most studies have used the Modified Fatigue Impact 
Scale (MFIS) or the Fatigue Severity Scale (FSS) to assess perceived fatigue. However, the 
psychometric properties of the MFIS152,159 and FSS156 have recently been questioned, making 
interpretation of results difficult. Studies using self-reported sleep quality (the Pittsburgh Sleep 
Quality Index (PSQI) and/or the Epworth Sleepiness Scale (ESS)) have found a significant 
association between sleep quality and perceived fatigue in PwMS.102,107,114 Unfortunately, only 
limited studies that have examined the association between perceived fatigue and sleep quality 
utilizing objective measures (PSG14,190,191 or actigraphy105,125,189), and those studies have 
conflicting results, with some finding an association between fatigue and sleep quality26,105 while 
others failed to find an association.36,125,189,191  Although an association between poor sleep 
quality and perceived fatigue has been widely reported, those studies differ in terms of the 
fatigue scales used, means of measuring sleep quality (self-report vs. objective), exclusion or 
inclusion of those with sleep disorders, and differences in the study sample’s disease severity 
(mild vs. severe), which can contribute to the conflicting results.   
The Neurological Fatigue Index (NFI-MS)25 was developed using the outcome measure 
development guidelines from the Food and Drug Administration (FDA)161 based on a detailed 
medical definition of fatigue in PwMS.24 Unlike the MFIS159 and FSS,156 the NFI-MS fits into a 
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Rasch model analysis155 that uses a psychometric approach to accurately represent responses and 
produce linear measurements. Furthermore, to our knowledge, the NFI-MS is the only validated 
fatigue scale that, along with physical and cognitive components, includes two separate sleep 
components, acknowledging the importance of sleep quality during the assessment of perceived 
fatigue in the MS population. The sleep components in the NFI-MS are “relief by diurnal sleep 
or rest” in which a higher score indicates fatigue is relieved by sleep or rest during the day, and 
“abnormal nocturnal sleep and sleepiness” in which a higher score indicates fatigue is attributed 
to fragmented sleep or reduced sleep quality during the night and daytime sleepiness.  
Only one prior study by Mills et al.122 has examined the relationship between the NFI-MS 
summary score and self-reported sleep quality and daytime sleepiness in PwMS.122 Perceived 
fatigue was higher in those that reported sleeping more during the day, fragmented nocturnal 
sleep, and higher daytime sleepiness. Therefore, the primary aim of this study is to expand the 
work of Mills et al. Specifically, it will explore the relationship between the NFI-MS and the 
gold-standard self-report sleep quality measure (the PSQI) and explore the relationship between 
the NFI-MS and objective sleep quality using actigraphy.  
3.3. Methods 
A cross-sectional study design was used and performed in accordance with the University of 
Kansas Medical Center’s (KUMC) Institutional Review Board. Participants were recruited from 
the MS clinic at KUMC and through personal referral from participants and area physicians. 
Eligibility for the study required participants to be (1) 18-60 years of age, (2) have relapsing-
remitting or secondary-progressive MS, (3) able to ambulate with or without an assistive device, 
and (4) score > 24 on the Mini Mental Status Exam (MMSE)177. The exclusion criteria includes 
the following: (1) history of alcohol/drug abuse or nervous system disorder other than MS, (2) 
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severe physical, neurological, or sensory impairments that would interfere significantly with 
testing, (3) developmental history of learning disability or attention-deficit/hyperactivity 
disorder, (4) relapse and/or corticosteroid use within four weeks of assessment, (5) untreated 
sleep disorder (such as sleep apnea), and (6) uncorrected vision loss that would interfere 
significantly with testing.  
Written informed consent was received from all study participants. Information regarding 
medical history, demographics, and medication use were collected. All study participants were 
instructed to refrain from consuming alcohol or caffeine beyond their normal daily consumption 
and refrain from taking medications other than the ones they usually take for the day of 
assessment. After completing a battery of questionnaires, each participant was given an actigraph 
device to objectively assess sleep quality. The participants were instructed to wear the actigraph 
on their dominant wrist for a week and return the actigraph using a postage-paid envelope. 
3.3.1. Perceived fatigue measure 
Perceived fatigue during the past two weeks was assessed using the Neurological Fatigue 
Index (NFI-MS).25 The NFI-MS consists of 23 questions, each on a Likert scale from 0-3 with 
higher score indicating more fatigue. The NFI-MS consists of four components: physical, 
cognitive, relief by diurnal sleep or rest, and abnormal nocturnal sleep/sleepiness. A higher score 
in the “relief by diurnal sleep or rest” component indicates fatigue is relieved by sleep or rest 
during the day. A higher score in the “abnormal nocturnal sleep/sleepiness” component indicates 
fatigue is attributed to fragmented sleep or reduced sleep quality during the night and daytime 
sleepiness. A summary score is calculated by adding together the physical and cognitive 




3.3.2. Sleep measures 
Self-reported sleep was measured using the Pittsburgh Sleep Quality Index (PSQI).108 The 
PSQI is a validated and well-known measure of sleep quality in which the participant reports 
their sleeping habits over the past month. It consists of 19 self-rated questions; each is rated on a 
scale of 0-3 with 0 indicating no sleep difficulty and 3 indicating severe sleep difficulties. The 
PSQI global score ranges from 0–21, with a score of > 5 indicating poor sleep quality.192 Seven 
component scores (sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep 
disturbances, use of sleep medication, and daytime dysfunction) were also calculated.  
Daytime sleepiness was measured using the Epworth Sleepiness Scale (ESS).109  The 
participant rates how likely they would doze off in eight different scenarios of daily activities. 
The eight ESS items use a 4-point Likert scale in which a higher score indicates higher daytime 
sleepiness.  
Actigraphy was utilized to objectively quantify sleep quality.113 An actigraph is a portable 
device that records movement over extended periods of time and has been used in the study of 
sleep and circadian rhythms in PwMS.105,125 Each participant was instructed to wear an actigraph 
device (Model wGT3X-BT®, ActiGraph corp. Pensacola, FL) on the dominant wrist for seven 
consecutive days. The participants were instructed to temporarily remove the watch during 
exposure to water (i.e. showering or swimming). The parameters of interest from the actigraph 
include: sleep efficiency (SE), total sleep time (TST), total time in bed (TTB), wake after sleep 





3.3.3. Other measures 
Participants completed the following assessments due to the possible association with 
fatigue and sleep quality in PwMS: the Patient Determined Disease Steps (PDDS)188 to assess 
disease severity, the Beck Depression Inventory (BDI)132 to assess depression, and the State Trait 
Anxiety Inventory (STAI)193 to measure both current anxiety using the state subscale (STAI-S) 
and general anxiety using the trait subscale (STAI-T).  
3.3.4. Data Analysis 
Wear time validation for the actigraph data was confirmed first using the following criteria: 
wear time of at least four valid days out of the seven days with a valid day defined as having a 
wear time of at least 600 minutes during a 24-hour period (12 am to 11:59 pm).194 ActiLife 
software (version 6.11.8) was utilized to analyze the sleep data using Cole-Kripke algorithm, 
which has been validated for use in adult populations between 35 and 65 years of age.195 The 
Cole-kripke method uses a seven-minute window to determine if each epoch is sleep or awake 
using the following algorithm: (.001 * (106 * Epochx-4 + 54 *Epochx-3 + 58 * Epochx-2 + 76 * 
Epochx-1 + 230 * Epochx+ 74 * Epochx+1+ 67 * Epochx+2). Any missing epochs are 
considered zero and if the result of the algorithm is ˂ 1, then the current epoch is considered as 
sleep. All data was entered into SPSS version 23 (IBM SPSS Statistics 23, ©IBM) for analysis. 
Assumptions of normality were first tested using the Shapiro-Wilk test and Normal Q-Q plots. 
Descriptive statistics were calculated for the demographics and all other variables. An 
established ordinal to interval scores of the NFI-MS are available to use for parametric testing.25 
Therefore, Pearson’s product correlations were utilized to explore the association between 
perceived fatigue and sleep quality. When the assumptions of normality were not met and for 
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ordinal data, Spearman’s product correlations were utilized to explore the associations between 
the outcome measures of interest. Alpha level was set at 0.05.  
3.4. Results 
Fifty-one participants (mean age of 47 years ± 10.1; 43 females) participated in the study. 
Forty-six participants had relapsing-remitting MS and five had secondary-progressive MS. The 
overall disease status of the sample was mild (PDDS: 1.8 ± 1.6), with minimal to mild 
depression (BDI: 3.7 ± 3.1), minimal general anxiety (STAI-T: 40.4 ± 10), and no severe global 
cognitive impairments (MMSE: 28.7 ± 1.6).  The study sample had on average poor self-reported 
sleep quality (PSQI: 8.1± 3.8 and ESS: 8.7 ± 4.5). Refer to Table 1 for descriptive statistics. 
3.4.1. Association between NFI-MS and self-reported sleep quality 
The NFI-MS physical component, abnormal nocturnal sleep/sleepiness component, and 
summary score were significantly associated with the PSQI global score (r= .427, p= .002; r= 
.566, p= ≤ .001; r= .388, p= .005, respectively; Table 2; Figure 1). The NFI-MS cognitive 
component and relief by diurnal sleep component were not associated with the PSQI global score 
(r= .231, p= .102 and r= .116, p= .419, respectively). 
Analysis of the components of the PSQI revealed that the daytime dysfunction component 
was significantly associated with all the NFI-MS components (Table 2), indicating  that higher 
daytime dysfunction is associated with higher perceived fatigue on all aspects of the NFI-MS 
(summary: r= .571, p= ≤ .001, physical: r= .545, p= ≤ .001, cognitive: .486, p= ≤ .001, relief by 
diurnal sleep: r= .316, p= ≤ .001, abnormal nocturnal sleep/sleepiness: r= .432, p= ≤ .001). The 
abnormal nocturnal sleep/sleepiness component of the NFI-MS was significantly associated with 
four of the PSQI components (sleep duration r= .414, p= .003; sleep disturbances r= .420, p= 
.004; daytime dysfunction r= .432, p= ≤ .001), indicating that higher perceived fatigue that is 
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attributed to abnormal nocturnal sleep/sleepiness is associated with lower sleep duration, higher 
sleep disturbances, and higher daytime dysfunction. The NFI-MS relief by diurnal sleep 
component was significantly associated with the PSQI daytime dysfunction component (Table 
2), indicating that higher fatigue that is relieved by diurnal sleep or rest is associated with higher 
daytime dysfunction.  
All the NFI-MS components were significantly associated with higher daytime sleepiness as 
measured using the ESS (summary: r= .341, p= .014, physical: r= .344, p= .013, cognitive: .296, 
p= .035, relief by diurnal sleep: r= .313, p= .025, abnormal nocturnal sleep and sleepiness: r= 
.377, p= .006; Table 2), indicating higher perceived fatigue on all aspects of the NFI-MS is 
associated with higher daytime sleepiness. 
3.4.2. Association between NFI-MS and objectively assessed sleep  
The study sample had an average SE of 89.5% ± 4.7, average TST 439.1 minutes ± 86, 
average TIB 489.3 minutes ± 85.4), a WASO of 48.2 minutes ± 21, and an average number of 
awakenings of 12.3 times ± 4.7; Table 3). None of the NFI-MS component scores were 
significantly associated with any of the actigraph sleep parameters (Table 4).  
3.5. Discussion 
This is the first study to examine the association between perceptions of fatigue using the 
NFI-MS and self-report and objective measures of sleep quality in PwMS. The findings of the 
current study indicate that poor self-report sleep quality is associated with increases in 
perceptions of fatigue in PwMS. However, objective sleep quality measured using actigraphy is 
not associated with perceived fatigue in this study sample.  
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The findings of this study support the results by Mills et al., which is the only other study 
that evaluated the relationship between the NFI-MS and sleep quality.122 Mills et al. measured 
sleep quality through self-estimating the hours of diurnal and nocturnal sleep and whether 
nocturnal sleep was fragmented throughout the night. Their findings showed that those who slept 
more during the day and had fragmented nocturnal sleep reported higher fatigue on the NFI-MS 
summary score. Similar to the current study, Mills et al. found a significant association between 
the NFI-MS summary score and the ESS score. Results from the current study demonstrate that 
self-report sleep quality but not objectively measured sleep quality is associated with self-
perceived fatigue in PwMS.  
It is difficult to compare our findings with other previous studies due to the variety of 
perceived fatigue measures used, but several studies had similar findings regarding the 
association between perceived fatigue and self-reported sleep quality measures.102,107,114 Strober 
et al.102 found significant associations between perceived fatigue measured using the MFIS and 
poor sleep quality measured using the PSQI. Similarly, Cameron et al.114 found significant 
associations between perceived fatigue measured using the MFIS and FSS and poor sleep quality 
measured using the PSQI. Stanton et al.107 found that excessive daytime sleepiness measured 
using the ESS was significantly associated with perceived fatigue measured using the FSS. 
Although these studies had similar findings to our results, what makes the current study 
significant and different is the use of the NFI-MS as a measure of perceived fatigue. Mills et al., 
who developed the NFI-MS, recommended researchers to reevaluate using the total scores of the 
MFIS and FSS.156,159 Those scores are considered invalid based on the Rasch analysis and thus 
would affect the interpretation of the findings of previous studies. The NFI-MS is a more 
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psychometrically sound scale of perceived fatigue compared to the commonly used ones and 
therefore interpreting the results would be more accurate.  
An important finding is the lack of association between perceived fatigue and the actigraph 
parameters. Previous studies that explored the relationship between actigraphy and perceived 
fatigue in PwMS had conflicting results, but comparing the current study findings with previous 
research is difficult due to different measures of perceived fatigue used.105,125,189 Perhaps the lack 
of association in the current study between perceived fatigue and the actigraph parameters is due 
to a limitation of actigraphy to accurately assess sleep in this sample. Evidence showed that the 
actigraph may overestimate sleep efficiency and total sleep time15,54 which may impact the 
interpretation of results.113,196 Furthermore, actigraphy findings might be limited by wear time. 
Perhaps PwMS need to wear the actigraph for more than one week to accurately assess their 
sleep quality. Attarian et al.105 who found significant associations between actigraphy and fatigue 
had the participants wear the actigraph for two weeks. Future studies are needed to verify these 
findings and explore if a longer wear time might more accurately assess sleep quality in PwMS.  
Due to the novel purpose of this study, statistical correction was not used despite the number 
of correlation analyses conducted. Furthermore, because the sample had mostly mild disease 
severity, the findings are not generalizable to those with more severe disease forms of MS. In 
addition, it is possible that there might be participants in the current study sample with an 
undiagnosed sleep disorder. It is acknowledged in the literature that a high percentage of PwMS 
are underdiagnosed with sleep disorders and therefore more emphasis should be put on this 
matter.100 Future studies may need to consider assessing the relationship between the NFI-MS 
and sleep quality in those with severe forms of MS and in those assessed for the presence of 
sleep disorders. We expect that the results of the current study would differ as evidence 
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demonstrates higher perceived fatigue in those with more disease severity and in those with sleep 
disorders such as insomnia and obstructive sleep apnea.23,135 Furthermore, the participants were 
allowed to continue the use of their normal medications on the day of the assessment, so taking 
sleep or fatigue-related medication may affect their responses to the questionnaires.  
The findings of the current study have important clinical implications. Sleep quality should 
be considered during both the assessment and management of fatigue in PwMS. The use of the 
NFI-MS can be easily utilized in research and clinical settings to assess the crucial role of poor 
sleep quality in relation to perceived fatigue in PwMS. The current study results emphasize the 
need for health care providers to consider address sleep disturbances as part of the perceived 
fatigue treatment plan in PwMS.  
3.6. Conclusions 
The current study findings demonstrate that higher perceived fatigue is significantly 
associated with poorer self-reported sleep quality and excessive daytime sleepiness, but not with 
objectively assessed sleep quality. The NFI-MS is an efficient method to assess and manage the 
role sleep quality has on perceived fatigue in the MS population. Future studies are needed to 












Table 2. Bivariate correlations between the NFI-MS and the self-reported sleep quality and 
daytime sleepiness measures. 
   NFI-MS  
 Summary Physical Cognitive 
relief by diurnal 
sleep or rest 
abnormal nocturnal 
sleep/sleepiness 






































































































Data is reported as correlation co-efficient r (p-value). * Correlation is statistically significant at 
an alpha level ˂ 0.05. NFI-MS: Neurological Fatigue Index, PSQI: Pittsburgh Sleep Quality 
Index, ESS: Epworth Sleepiness Scale. 





















Data is reported as mean (standard deviation). SE: Sleep Efficiency, TST: Total Sleep Time, 
WASO: Wake After Sleep Onset, TTB: Total Time in Bed. 
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Table 4. Bivariate correlations between the NFI-MS and the Actigraph parameters. 
                NFI-MS  
Actigraph Summary Physical Cognitive 
Relief by diurnal 






































































Data is reported as correlation co-efficient r (p-value). * Correlation is statistically significant at 
an alpha level ˂ 0.05. NFI-MS: Neurological Fatigue Index, SE: Sleep Efficiency, TST: Total 











3.8. Figure Legend 
Figure 1. Scatter plot between the PSQI global score and the NFI-MS physical component (A) 
the abnormal nocturnal sleep/sleepiness component (B) and the summary score (C). PSQI: 
Pittsburgh Sleep Quality Index, NFI-MS: Neurological Fatigue Index.  
3.9. Figures 
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Background: Perceived fatigue and fatigability are constructs of multiple sclerosis (MS) related 
fatigue. Sleep disturbances leads to poor sleep quality which has been found to be associated 
with perceived fatigue in people with MS (PwMS). However, the relationship between 
fatigability and sleep quality is unknown. Objective: To explore the relationship between 
physical and cognitive fatigability with self-reported and objective measures of sleep quality in 
PwMS. Methods: Fifty-one ambulatory PwMS participated in the study. Physical fatigability 
was measured by percent-change in meters walked on the Six-Minute Walk Test (6MWT) and in 
force exerted on a repeated maximal hand grip test. Cognitive fatigability was measured using 
response speed variability on the continuous performance test. Self-report sleep quality was 
measured using the Pittsburgh Sleep Quality Index, and objective sleep quality was measured 
using 1 week of actigraphy. Results: Components of the Pittsburgh Sleep Quality Index and 
several actigraph parameters were significantly associated with physical fatigability and 
cognitive fatigability. Conclusion: Poor sleep quality is related to fatigability in MS. Clinicians 
and researchers need to consider the role poor sleep quality has on physical and cognitive 









Multiple sclerosis (MS) related fatigue is one of the most debilitating symptoms affecting 
people with MS (PwMS).1 It interferes with daily function and is a major cause of 
unemployment.7  MS related fatigue is an umbrella term consisting of two different constructs: 
perceived fatigue and fatigability.19 Perceived fatigue is reported by the individual as tiredness in 
performing physical and cognitive tasks that interfere with daily function.18 Fatigability can be 
objectively quantified by a clinician or researcher and is the measure of change in the 
performance of physical or cognitive tasks over a period of time.19 Physical fatigability is the 
reduced ability to complete sustained physical tasks such as walking constantly for several 
minutes.19 Cognitive fatigability19 is described as the inability to sustain concentration and 
attention during demanding cognitive tasks such as following conversations. 
Approximately 60% of PwMS report experiencing sleep disturbance that eventually results 
in overall poor sleep quality.98 Evidence suggests that sleep disturbances might exacerbate MS-
related fatigue through excessive activation of the central nervous system (CNS).115 The 
excessive activation of the CNS may result from recurrent sleep arousals, central mechanisms 
such as lesions on the suprachiasmatic nucleus in the hypothalamus that regulates circadian 
rhythms, and elevated certain inflammatory cytokines in the cerebrospinal fluid that are 
associated with both sleep disturbances and increased MS-related fatigue.115 Poor sleep quality 
has been associated with a reduction in several quality of life indices including physical function, 
psychological well-being, and work ability.11 Furthermore, reduced sleep quality is associated 
with increased perceived fatigue in PwMS.13,102,105,114 However, it is unknown if poor sleep 
quality is associated with fatigability in PwMS. Understanding the relationship between 
fatigability and sleep quality will emphasize the need to consider sleep quality as an important 
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clinical characteristic during the management of MS-related fatigue, specially that sleep 
disturbances are often overlooked by clinicians in PwMS.101 Fatigue is one of the most 
frequently reported symptoms of MS, so if poor sleep quality is found to be associated with 
fatigability in PwMS, then management of sleep disturbances could lead to improvements in 
fatigability and associated improvement in daily function for PwMS. Therefore, the purpose of 
this study was to investigate the relationship between fatigability and self-report and objectively 
assessed sleep quality in PwMS.  
Due to the involvement of the aforementioned central mechanisms in sleep disturbances and 
MS-related fatigue as well as the previous evidence that shows an association between poor sleep 
quality and perceived fatigue in PwMS, we hypothesized that poor sleep quality would be 
associated with physical and cognitive fatigability in PwMS.  
4.3. Materials and Methods 
4.3.1. Participants 
Participants were recruited from the MS clinic at the University of Kansas Medical Centre 
(KUMC) and through personal referral from consented participants. The inclusion criteria were 
(1) 18-60 years of age, (2) relapsing-remitting or secondary-progressive MS,176 (3) ability to 
ambulate with/without an assistive device, and (4) a score > 24 on the Mini Mental Status Exam 
(MMSE).177 Participants were excluded if they had (1) a history of alcohol/drug abuse or nervous 
system disorder other than MS, (2) severe physical, neurological, or sensory impairments that 
would interfere significantly with testing, (3) developmental history of learning disability or 
attention-deficit/hyperactivity disorder, (4) relapse and/or corticosteroid use within four weeks of 
assessment, (5) known untreated sleep disorder (such as sleep apnea), (6) uncorrected vision loss 
that would interfere significantly with testing, (7) acute ischemic cardiovascular event or 
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coronary artery bypass surgery less than 3 months ago, and (8) uncontrolled blood pressure with 
medication (BP > 190/110mmHg). The study protocol was approved by the KUMC institutional 
review board.  
4.3.2. Procedure 
Participants were instructed to refrain from exercise for at least 24 hours prior to testing day, 
consuming caffeine beyond typical daily consumption, and taking medications other than the 
ones they typically use. Participants first underwent a battery of questionnaires to assess their 
mood and sleep quality then performed the fatigability measures in random order. After the 
assessment, each participant was given an actigraph device and instructed to wear it for a week. 
Medical history and demographic characteristics were obtained from all the participants. 
4.3.3. Sleep measures 
The Pittsburgh Sleep Quality Index (PSQI)108 was utilized to measure self-report sleep 
quality over the past month. The PSQI is comprised of seven different components scores as well 
as a single global score ranging from 0–21 with a higher score indicating worse sleep quality.  
An actigraph was used to objectively quantify sleep quality. Actigraphy is a cost effective 
method to measure sleep/wake cycles and has been used in PwMS.113 Each participant was given 
an actigraph device (Model wGT3X-BT®, ActiGraph corp. Pensacola, FL) with a stamped 
envelope to return it via USPS. Instructions were to wear the actigraph on their dominant wrist 
for seven consecutive days and remove it only during showering or swimming. The parameters 
of interest from the actigraph include: sleep efficiency, total sleep time, total time in bed, wake 
after sleep onset, and number of awakenings. 
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4.3.4. Fatigability measures 
Detailed information about the method of administration and scoring of the fatigability 
measures is described elsewhere.197 In short, physical fatigability was measured using change in 
performance on the Six-Minute Walk Test (6MWT) and hand held dynamometer grip strength 
test. The 6MWT has been previously modified in administration and scoring to assess physical 
fatigability in PwMS.55 In addition, time-remaining prompts were eliminated and participants 
were not informed of the test length. Physical fatigability was calculated as a percent change in 
the distance walked between the first and sixth minute.  
The second measure to assess physical fatigability was change in performance on a grip 
strength test previously used in PwMS.57 Participants performed 15 trials of maximal hand grip 
contractions using a JAMAR hydraulic hand-held dynamometer,57 holding each contraction for 
five seconds, with a five-second rest between repetitions. The examiner informed the participants 
when to squeeze the handle by saying “Squeeze now” and then continue squeeze maximally until 
the examiner said “Stop”. A metronome heard only by the examiner using a headset was used to 
maintain the five-second intervals. Physical fatigability was calculated by measuring the percent 
change in kilograms (kg) between the first and last trial. The test was first administered using the 
dominant hand and then repeated using the non-dominant hand.  
The Continuous Performance Test (Connors 3™)64 was utilized to assess cognitive 
fatigability using the Response Speed Variability (RSV) score. RSV  was previously found to be 
effective in detecting cognitive fatigability in PwMS.56 The mean RSV T-score, the primary 
outcome measure of the RSV of the participant was used as the main outcome variable. 
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4.3.5. Other measures 
To demonstrate that the fatigability tests were fatiguing the participants, current 
perceptions of fatigue were assessed immediately preceding and following each measure using 
the 1 item visual analog fatigue scale.150 The participants placed a mark (X sign) on a 100 mm 
line between “not at all fatigued” to “extremely fatigued” to indicate their current level of 
fatigue. The outcome measure was the value of the length in mm along the line the participants 
placed the mark at. Participants also completed the Beck Depression Inventory-Fast Screen132 to 
assess depression and the Patient Determined Disease Steps188 which measures disease status in 
PwMS. 
4.3.6. Actigraph data analysis 
ActiLife software (version 6.11.8) was used to perform wear time validation and to analyze 
the sleep data using the Cole-Kripke algorithm which has been validated for use in adult 
populations.195 To be included in the data analysis, participants had to have at least four valid 
days of wear time (a valid day was defined as at least 10 hours of wear time per day which is 
equivalent to 600 minutes).194  
4.3.7. Statistical analysis 
Data were entered into SPSS version 23 (IBM SPSS Statistics 23, ©IBM) for statistical 
analysis. Descriptive statistics were calculated for the demographics and all other variables and 
assumptions of normality were tested using the Shapiro-Wilk test. If assumptions of normality 
were met for continuous variables, Pearson’s product correlations were utilized to explore the 
association between the fatigability measures and sleep quality measures. Spearman’s product 
correlations were utilized when the assumptions of normality were not met and in variables of 
ordinal level. Differences in pre- and post-testing acute perceptions of fatigue measured using the 
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1-item visual analogue fatigue scale were analyzed using Wilcoxon Signed-Rank tests. Alpha 
level was set at 0.05. 
4.4. Results 
Fifty-one individuals participated in this study with a mean age of 47 years old ± 10.1, mild 
disease severity 1.8 ± 1.6, and minimal to mild depression 3.7 ± 3.1 (Table 1). Actigraph details 
are listed in Table 2.   
4.4.1. Fatigability and current perceived fatigue 
Results of the fatigability measures and the VAFS is described elsewhere.197 Briefly, there 
was a decrease in meters walked on the 6MWT by 12.7% (p < .001), the force exerted in the grip 
strength test decreased by 35.9% on the dominant hand (p < .001) and 33.2% on the non-
dominant hand (p < .001), and current perceived fatigue was significantly higher following 
performance of each fatigability measure (p ˂ .001 on all tests).   
4.4.2. Association between physical fatigability and self-reported sleep quality 
There were no significant associations between the PSQI global score and any of the 
physical fatigability measures (Table 3). There was a significant association between the sleep 
duration component of the PSQI and grip test percent change in the dominant hand (rho= -.397, 
p= .004) and non-dominant hand (rho= -.366, p= .008). There was also a significant association 
between the sleep quality component (a single self-rating question of the overall sleep quality) 
and the grip test percent change of the non-dominant hand (rho= -.284, p= .043). The 6MWT 




4.4.3. Association between cognitive fatigability and self-reported sleep quality 
There was no significant association between the PSQI global score and the cognitive 
fatigability measure (Table 3). The RSV score was significantly associated with the daytime 
dysfunction component of the PSQI (rho= .303, p= .030). There was no significant association 
between cognitive fatigability and the remaining PSQI components (Table 3). 
4.4.4. Association between physical fatigability and actigraphy sleep quality 
The 6MWT percent change score was significantly associated with the average awakenings 
time (rho=-.393, p= .004). The grip test percent change score of the non-dominant hand showed 
a significant association with sleep efficiency (r= .364, p= .009) and total sleep time (r=.357, p= 
.010). The grip test percent change score of the non-dominant hand was also significantly 
associated with wake after sleep onset (r=-.311, p= .026). The remaining actigraph parameters 
were not significantly associated with the fatigability measures (Table 4).  
4.4.5. Association between cognitive fatigability and actigraphy sleep quality 
The RSV score was significantly associated with sleep efficiency (r=-.342, p= .015). The 
variability score was also significantly associated with wake after sleep onset (r=.294, p=.039). 
Cognitive fatigability was not associated with the remaining actigraph parameters (Table 4). 
4.5. Discussion 
This is the first study that explored the relationship between physical and cognitive 
fatigability and sleep quality in PwMS. The findings demonstrate that less reported time spent 
sleeping is associated with higher physical fatigability and higher cognitive fatigability is 
associated with higher daytime dysfunction. The findings using actigraphy indicate that higher 
physical fatigability is associated with a longer duration of awakenings during the night, higher 
physical fatigability is associated with lower sleep efficiency, lower total sleep time, and longer 
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wake time after the initiation of sleep. Higher cognitive fatigability is associated with lower sleep 
efficiency and longer wake time after the initiation of sleep. These findings agree with our 
hypothesis that poor sleep quality would be associated with physical and cognitive fatigability in 
PwMS. 
The fatigability measures utilized in this study resemble everyday life activities (walking, 
hand motion, sustained attention, etc.) and these activities are fatiguing the participants based on 
the significant deterioration in performance and the significant increase in acute perceptions of 
fatigue. In line with our findings, Goldman et al55 showed deterioration in walking performance 
during the 6MWT in PwMS compared to healthy controls. Functional neuroimaging evidence 
demonstrates an association between decreased activation of motor and non-motor cortico-
subcortico pathways in the brain during the execution of a motor task in PwMS.74 The motor 
tasks represented in the present study are the 6MWT and hand grip test which both showed 
deterioration in performance for PwMS and are interpreted as physical fatigability. The 
correlation between physical fatigability and poor sleep quality based on actigraph measures may 
be explained through central mechanisms that involve decreased activation of non-motor 
pathways that are involved in regulating sleep quality like the hypothalamus, and through 
elevated inflammatory cytokines in the CNS that are associated with increased MS-related 
fatigue and sleep disturbances in PwMS. Poor sleep quality seems to exacerbate physical 
fatigability in PwMS and therefore should be considered as part of the management plan of MS-
related fatigue.  
The RSV measure has previously shown to be higher in PwMS compared to healthy 
controls,56 and neuroimaging studies found higher RSV is associated with dysfunction of the 
fronto-cortical networks and decreased white matter brain volume.75 It is possible that 
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dysfunction of the fronto-cortical networks might be partially explained by the imbalance of 
certain inflammatory cytokines that are associated with sleep disturbances in PwMS. 
Furthermore, the decreased white matter volume may cause dysfunction in regions that regulates 
sleep quality, specially that evidence demonstrates a strong association between white matter 
volume and sleep disorders such as sleep apnea in the general population.198 Future studies are 
needed to verify these conclusions. 
In the present study, actigraph sleep parameters were significantly correlated with grip 
physical fatigability differently based on hand dominance. Severijns et al.57 used a similar hand 
grip test protocol to measure fatigability in PwMS and showed that despite a deterioration in 
performance during the test of both hands, there was no significant difference in physical 
fatigability based on hand dominance or affected side in PwMS. The authors argued that the 
involvement of central factors rather than peripheral muscle weakness influenced the findings.57 
A recent functional neuroimaging study showed that PwMS demonstrated a decline in the 
activation of cortical motor and non-motor regions during a sustained motor task compared to 
healthy controls, suggesting the involvement of central factors with fatigability.74 Therefore, it is 
likely that the significant association between the actigraph and physical fatigability of the non-
dominant hand but not with the dominant hand in the current study is not due to hand dominance. 
Instead, it is possible that failure of the motor central regions to excite hand muscles was further 
exacerbated during the grip test on the non-dominant hand as it always followed the dominant 
side test. Further studies are needed to verify these conclusions and perhaps explore if a resting 
period between the two tests might change the findings.   
The current study found that actigraph sleep parameters showed more relationships with 
physical fatigability measures than self-report sleep parameters. One possible explanation is the 
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previously reported lack of agreement between self-report sleep quality on the PSQI and 
objective sleep measures using actigraphy199: 1) PwMS have been shown to underestimate their 
sleep quality on the PSQI200, 2) the length and time period of reporting the two sleep quality 
measurements is different; one month for the PSQI reported before the assessment vs. 1-week for 
actigraphy measured after the assessment. Furthermore, actigraphy has also been shown to 
overestimate sleep efficiency and total sleep time.196 Future studies are necessary to explore if 
having the actigraph measurement overlap with the PSQI reports would yield more agreement 
between the sleep quality measures.  
The current study has some limitations. First, generalizability is limited as the sample had 
mild disease severity and mostly relapsing-remitting MS. However, our findings are clinically 
important as they demonstrated the association between poor sleep quality and fatigability in a 
sample of individuals with mild disease impairments. Another limitation is the participants were 
instructed to continue taking their usual medications on the day of the assessment. This might 
affect the results by improving or inhibiting performance and responses on the tests depending 
on the medication, but our results clearly show there are still detriments in performance as well 
as poor sleep quality even with the usage of fatigue or sleep related medications. In addition, 
keeping the participants on their usual medication provide clinically relevant information as it 
reflects their normal daily habits. 
Around 50% of PwMS have a diagnosable sleep disorder, but a much higher percentage of 
sleep disorders remain undiagnosed.100 Although individuals with an known untreated sleep 
disorder were excluded from participating in the current study, it is possible that there were 
participants with an undiagnosed sleep disorder which may have influenced our findings. There 
is evidence suggesting a significant association between obstructive sleep apnea and higher 
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perceived fatigue in PwMS,116 and based on the findings of the current study we expect the 
presence of sleep disorders would affect the performance of physical and cognitive tasks. Future 
studies should consider actively screening for sleep disorders and then explore the relationship 
between sleep disorders and fatigability in PwMS. In addition, future studies may explore if 
treatment of sleep disorders or sleep disturbances improve fatigability, as evidence suggests that 
treating sleep disorders significantly decreases perceived fatigue in PwMS.121 In sum, clinicians 
should consider sleep assessment and management as part of their treatment and rehabilitation 
plan.  
Fatigability is an important construct of MS-related fatigue that is a common debilitating 
symptom in the MS population. What makes the current study findings significant is that poor 
sleep quality (self-reported and actigraphy) is related to decreased task performance in both 
physical and cognitive aspects, which is likely clinically meaningful. As fatigability is related to 
the ability to efficiently perform tasks that require effortful activity such as walking or engaging 
in a conversation,19 poor sleep quality may further aggravate fatigability and may worsen the 
performance of everyday life tasks. Therefore, sleep quality should be considered as an 
important clinical characteristic during the assessment and management of MS-related fatigue. 
More emphasis should be put on considering the role of sleep quality on exacerbating fatigue and 
exploring the effect of treating sleep disorders on fatigability in PwMS. Future studies might also 
need to explore the effect of non-pharmacological treatments of poor sleep quality such as sleep 






Table 1. Demographic and clinical characteristics of the study sample. 



























Data is reported as mean (standard deviation). RR: Relapsing Remitting MS, SP: Secondary 
Progressive MS  
 




























































Data is reported as correlation co-efficient r (p-value). * Statistically significant, p ˂ 0.05. PSQI: 








 Fatigability Measures  
PSQI 6MWT 
%change 
Grip test % 
change 
Dominant 




Global -.040 (.781) -.216 (.128) -.125 (.382) .045 (.755) 
Sleep quality .100 (.487) -.212 (.136) -.284* (.043) .064 (.656) 
Sleep latency -.175 (.221) -.120 (.401) -.034 (.812) -.068 (.635) 
Sleep duration .074 (.604) -.366* (.004) -.366* (.008) .112 (.434) 
Sleep efficiency .036 (.801) -.265 (.061) -.106 (.459) -.070 (.624) 
Sleep disturbances .027 (.852) .029 (.841) -.133 (.353) -.031 (.832) 
Sleep medication -.046 (.748) .082 (.568) .082 (.569) -.049 (.733) 
Daytime dysfunction -.015 (.917) -.103 (.472) -.034 (.811) .303* (.030) 
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Table 4. Bivariate correlation analysis between the fatigability measures and the actigraph sleep 
parameters. 
                            Fatigability Measures  
Actigraph 6MWT 
%change 
Grip test % 
change 
Dominant 




Sleep Efficiency .080 (.574) .128 (.371) .364* (.009) -.342* (.015) 
Total Sleep Time -.220 (.122) .242 (.088) .357* (.010) -.028 (.849) 
Wake After Sleep Onset -.137 (.337) -.128 (.371) -.311* (.026) .294* (.039) 
Total Time In Bed -.249 (.079) .259 (.067) .254 (.073) .048 (.740) 
Number of Awakenings .181 (.204) -.050 (.725) -.066 (.645) .163 (.257) 
Average Awakening time -.393* (.004) -.044 (.760) -.240 (.090) .142 (.326) 
Data is reported as correlation co-efficient r (p-value). * Statistically significant, p ˂0.05. 








































One of the widely used measures of perceived fatigue in the MS population is the Modified 
Fatigue Impact Scale (MFIS).201 The MFIS was created as a modified version of the Fatigue 
Impact Scale (FIS),148 it specifically measures perceptions of fatigue in people with MS (PwMS) 
on three aspects reported in the past four weeks: physical, cognitive, and psychosocial. The 
MFIS was recommended for use by the Multiple Sclerosis Council for Clinical Practice 
Guidelines.170  
The recently validated Neurological Fatigue Index (NFI-MS) by Mills et al.25 measures 
perceived fatigue reported in the past two weeks in PwMS. The NFI-MS generates four different 
components: physical, cognitive, and two sleep related components. The NFI-MS was developed 
following the standards from the FDA and following a proper psychometric model analysis for 
developing patient reported outcomes.25  
The NFI-MS is not commonly used in clinical practice or research, and it is unknown if the 
NFI-MS physical and cognitive domains agree with the physical and cognitive domains of the 
MFIS. During the validation process of the NFI-MS, the physical and cognitive domains of the 
scale were moderately to strongly correlated with the physical and cognitive domains of the 
MFIS (r=.72 and r=.69 respectively).25 However, a high correlation does not necessary imply 
that the two measures agree.202 Therefore, the purpose of Chapter 5 was to explore the agreement 
level between the physical domains of the NFI-MS and MFIS and the agreement level between 
the cognitive domains of the NFI-MS and the MFIS in PwMS. If both measures showed 
sufficient agreement, the NFI-MS can be used interchangeably with the MFIS to measure 
physical and cognitive perceptions of fatigue in PwMS. 
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5.2. Methods  
5.2.1. Procedure 
The current study utilized a cross sectional study design. All the study procedures and 
details are described elsewhere (Chapter 2, Chapter 3, and Chapter 4). On the day of the 
assessment, all the participants completed the NFI-MS first and then the MFIS.  
5.2.2. Measures 
The Neurological Fatigue Index (NFI-MS): Consists of 23 item, each on a Likert scale from 
0-3, with higher score indicating more perceived fatigue. The NFI-MS measures perceived 
fatigue under three domains: physical, cognitive, and sleep quality. For the purposes of this 
chapter, only the physical domain and cognitive domain were used in data analysis. The physical 
domain of the NFI-MS consists of eight items with a score ranging from 0-24. The cognitive 
domain of the NFI-MS consists of four items ranging from 0-12.  
The Modified Fatigue Impact Scale (MFIS): consists of 21 items, each on a Likert scale 
from 0-4, with higher score indication more perceived fatigue. The MFIS generates three 
components: physical, cognitive, and psychosocial. For the purposes of this chapter, only the 
physical domain and cognitive domain were used in data analysis. The physical domain of the 
MFIS consists of nine items with a score ranging from 0-36. The cognitive domain of the MFIS 
consists of ten items ranging from 0-40.  
5.2.3. Data Analysis 
Data was analyzed using SPSS version 23 (IBM SPSS Statistics 23, ©IBM). Descriptive 
statistics were calculated for the demographics. Bland-Altman analysis was utilized to explore 
the level of agreement between first the physical domains of the NFI-MS and the MFIS, then 
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between the cognitive domains of the NFI-MS and the MFIS.202,203 A one sample t-test was first 
used to explore if there is a significant variation from zero between the two measures, in which 
the difference in the scores was the test variable.  Bland-Altman plots were constructed to 
visually explore the anomalies and trends across the data points. On each plot, the mean 
difference horizontal line was plotted, and the upper and lower 95% confidence limit lines were 
plotted using the formulae ((standard deviation of the difference * 1.96) ± mean of the 
difference). To explore if there is a significant proportional bias across the data points, linear 
regression was utilized were the mean difference was set as the dependent variable and the mean 
of the two measures was set as the independent variable. Alpha level was set at ≤ 0.05. 
5.3. Results 
A total of 52 participants with a mean age of 46.8 years old (± 10.1 SD) were included in the 
analysis. Forty-four females and eight males participated, 47 with relapsing-remitting MS and 
five with secondary-progressive MS. Participants presented mostly with mild disease (PDDS 1.8 
± 1.6), and an average disease duration of 12.5 ± 7.6. 
5.3.1. Agreement between the physical domains 
The mean difference value of the two measures was -5.13, the upper confidence limit was 
3.28, and the lower confidence limit was -13.55. The initial analysis showed that there was a 
significant difference between zero and the mean difference of the two scales (p ≤ .001). This 
means the two scales are significantly different from each other and they cannot show a useful 
level of agreement. This finding is further supported by the regression analysis that showed a 
significant proportional bias between the two measures (p ≤ .001). Refer to Figure 1 for the 
Bland-Altman plot.  
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5.3.2. Agreement between the cognitive domains 
The mean difference value of the two measures was -12.17, the upper confidence limit was -
0.23, and the lower confidence limit was -24.06. The initial analysis showed that there was a 
significant difference between zero and the mean difference of the two scales (p ≤ .001). This 
means the two scales are significantly different from each other and they cannot show a useful 
level of agreement. This finding is further supported by the regression analysis that showed a 
significant proportional bias between the two measures (p ≤ .001). Refer to Figure 2 for the 
Bland-Altman plot.  
5.4. Discussion and Conclusions 
The findings demonstrate that the physical and cognitive domains of the NFI-MS and the 
MFIS significantly differ from each other in how they measure perceptions of physical and 
cognitive fatigue in a sample of mild disease MS. Also, the physical and cognitive domains of 
the two measures do not show useful level of agreement measured using the Bland-Altman 
analysis. 
Based on the findings of Chapter 5, one can conclude that the NFI-MS cannot be used 
interchangeably or replace the use of the MFIS to measure perceived physical and cognitive 
fatigue in PwMS. Based on the mean difference values and the values of the data points across 
the Bland-Altman plots, it seems that the MFIS overestimates perceptions of fatigue compared to 
the NFI-MS. The lack of agreement between the two measures can be explained by several 
reasons. First, recent evidence shows some concerns regarding the psychometric properties of the 
MFIS.152,159 According to Mills et al.159 specific items from the physical and cognitive 
components of the MFIS should be removed for the scale to fit the Rasch model. The Rasch 
model analysis is a recommended psychometric approach to develop and refine patient reported 
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outcomes.155 In addition, different components of the MFIS scale, i.e., items on the cognitive 
subscale and items on the physical subscale interact and affect the scale’s accuracy and the 
interpretation of its results. On the other hand, the NFI-MS physical and cognitive domains fits 
in to the Rasch model analysis and no further evaluation of their items is needed.25 Therefore, the 
lack of agreement might be explained by the presence of those items in the scale that Mills et al 
recommended its removal for a more accurate assessment of fatigue. Future studies should 
explore the agreement between the two measures after the removal of the recommended items 
from the MFIS. 
Furthermore, we believe that part of the lack of agreement between the cognitive domains of 
the two measures might be due to the large number of cognitive items on the MFIS compared to 
the low number of items on the NFI-MS (10 items compared to four items respectively). In 
addition, the difference in the scoring value between the two measures might affect the results. 
The MFIS will always generate a higher score that the NFI-MS especially for those that report 
higher levels of fatigue. This because the Likert scale range on the MFIS is 0-4 compared to 0-3 
on the NFI-MS.  
In summary, the NFI-MS cannot replace the use of the MFIS to measure perceptions of 
physical and cognitive fatigue in PwMS with mild disease forms. Future studies are needed to 
verify these conclusions and explore if evaluating the psychometric properties of the MFIS 






5.5. Figure legends 
Figure 1. Bland-Altman plot between the physical domains of the NFI-MS and MFIS. NFI-MS: 
Neurological Fatigue Index, MFIS: Modified Fatigue Impact Scale. 
Figure 2. Bland-Altman plot between the physical domains of the NFI-MS and MFIS. NFI-MS: 
Neurological Fatigue Index, MFIS: Modified Fatigue Impact Scale. 
5.6. Figures 




















































































6.1. Summary of findings 
The research and body of work presented in the current study aimed to understand the 
relationship between perceptions of fatigue, fatigability, and sleep quality in people with MS 
(PwMS). MS-related fatigue is a complex multidimensional symptom that significantly degrades 
the functional life of PwMS.4-7 Sleep disturbances are common in the MS population and are 
more likely to increase MS-related fatigue. 14,21-23 Perceived fatigue is a construct of fatigability 
that was studied extensively in previous research.19,49,50 However, there have been recent 
concerns regarding the psychometric properties of the most commonly used scales of perceived 
fatigue in PwMS.156,159 Our study utilized a more psychometrically sound scale of perceived 
fatigue called the Neurological Fatigue Index (NFI-MS) that is validated for use in PwMS.25  
One of the primary goals of this research was to explore the relationship between perceived 
fatigue using the NFI-MS and physical and cognitive fatigability. Our findings demonstrated that 
perceived physical fatigue is not associated with physical fatigability, while physical and 
cognitive perceived fatigue were associated with cognitive fatigability (Chapter 2). We also 
explored the relationship between the NFI-MS and sleep quality that is measured using self-
reported scales and objectively using 1-week actigraphy. Our results showed that perceived 
fatigue is associated with only self-reported sleep quality but not with any of the actigraph 
parameters (Chapter 3). Finally, we explored the relationship between fatigability and sleep 
quality which to our knowledge has never been explored before. Our findings showed that 
physical and cognitive fatigability are both associated with several self-reported and objective 
sleep quality parameters (Chapter 4). This chapter summarizes the findings presented in this 
body of work and discusses important clinical implications, limitations of our research, and 
future directions for which studies should be based. 
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6.1.1. Chapter 2. The relationship between fatigability and perceived fatigue measured using the 
Neurological Fatigue Index in people with MS 
Previous studies that explored the relationship between perceived fatigue and fatigability 
had conflicting results.55,58 None of those previous studies measured perceived fatigue using the 
NFI-MS. Instead, those studies used the most common perceived fatigue scales that are recently 
being questionable in terms of their psychometric properties. The main purpose of Chapter 2 was 
to explore the relationship between the NFI-MS and measures of physical and cognitive 
fatigability in PwMS. We utilized in the current study physical and cognitive measures that had 
been previously modified and used to capture physical and cognitive fatigability in 
PwMS.55,57,63,181 We further modified these tests to better capture fatigability in our sample. 
Physical fatigability was measured through percent change in meters walked on the six Minute 
Walk Test (6MWT), percent change in the force exerted on a repetitive grip strength test, and 
Response Speed Variability (RSV) measured using the Continuous Performance Test (CPT). We 
further determined whether the fatigability measures were fatiguing the participants by 
measuring their current perceptions of fatigue right before and after performing each fatigability 
measure. We initially hypothesized that due to proper psychometric evaluation and validation of 
the NFI-MS together with items within the scale that reflect fatigability, there will be significant 
associations between the NFI-MS and physical and cognitive fatigability. However, our results 
demonstrated an association between the NFI-MS and cognitive fatigability, not with physical 
fatigability.  
Although it is believed that the etiology behind both perceived fatigue and fatigability is due 
to dysfunction of the motor and cognitive cortical and subcortical networks centrally,9,19,47,67 
peripheral factors might also be involved with physical fatigability.18,67 This may explain the lack 
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of association between perceived fatigue and physical fatigability in our sample. Furthermore, 
we believe that the physical component of the NFI-MS may lack items that objectify 
performance fatigability and that might have affected the results. On the other hand, perceived 
fatigue and physical fatigability might simply be independent constructs, and in order to measure 
MS-related fatigue, measures of perceived fatigue and fatigability should be utilized collectively 
in both research and clinical settings. The fatigability measures further demonstrated that they 
are fatiguing the participants in our study, which was presented by both a significant detriment in 
performance and a significant increase in current perceived fatigue post testing. Future studies 
are needed to verify these conclusions.  
6.1.2. Chapter 3. The relationship between sleep quality and perceived fatigue measured using 
the Neurological Fatigue Index in people with MS 
The relationship between perceived fatigue and sleep quality has been studied extensively 
before, especially in the last several years, as more attention is being drawn towards the effect of 
sleep disturbances and sleep disorders on several life indices in the MS population.19,28-34 What 
makes the current body of work significant and different is the utilization of the NFI-MS as a 
measure of perceived fatigue. The NFI-MS was developed following the standards of a proper 
psychometric model analysis for developing patient reported outcomes.25 Furthermore, to our 
knowledge the NFI-MS is the only validated perceived fatigue scale that has two sleep 
components acknowledging the importance of considering sleep quality as a factor when one 
wants to assess perceived fatigue in PwMS. Chapter 3 focused on exploring the relationship 
between the NFI-MS and sleep quality in PwMS. We utilized self-reported and objective 
measures of sleep in the current study. Specifically, we used the gold standard self-reported sleep 
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quality scale, the Pittsburgh Sleep Quality Index (PSQI) and the Epworth Sleepiness Scale 
(ESS). We used one week of actigraphy to objectively quantify sleep quality in our study sample. 
 Our findings demonstrated that perceived fatigue was associated with poorer self-reported 
sleep quality but not with any of the actigraph parameters. We argue that perhaps the 
underestimation of the self-reports200 vs the overestimation of the objective measure113,196 
affected the results. Furthermore, there was no overlap between the time we gave the actigraph to 
the participants and the time they reported their sleep quality, which might have affected the 
findings. In addition, a longer actigraph wear time of two weeks might be needed to detect poor 
sleep quality in our study sample. Attarian et al.105 who found associations between perceived 
fatigue and actigraph parameters in PwMS, had a longer actigraph wear time of two weeks. 
However, our results support previous research in that higher perceived fatigue is associated with 
poorer sleep quality in PwMS. Specifically, higher perceived fatigue that is attributed to 
abnormal nocturnal is associated with poorer self-reported sleep quality in our study sample. The 
NFI-MS can be easily administered and scored in clinical and research settings to measure the 
effect sleep quality has on perceived fatigue in PwMS. 
6.1.3. Chapter 4. The relationship between fatigability and sleep quality in people with MS 
It is believed that fatigability in PwMS may result from a dysfunction in motor and cognitive 
networks in several cortical regions in the brain and the spinal cord in PwMS.19,204 Furthermore, 
it is thought that sleep disturbances result from excessive activation of the central nervous 
system, hence its association with perceived fatigue.116 However, the relationship between sleep 
quality and fatigability have never been studied before. Therefore, the main aim of Chapter 4 
was to explore the relationship between physical and cognitive fatigability with sleep quality in 
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PwMS. Due to the involvement of central factors of both fatigability and sleep quality, we 
hypothesized that both will be associated.  
We utilized the same fatigability measures used in chapter 2, and the same sleep quality 
measures from chapter 3. Our results showed that poorer self-reported sleep quality was 
associated with higher physical fatigability on both the 6MWT and grip test, and was also 
associated with higher cognitive fatigability. Several parameters from the actigraph were 
associated with higher grip physical fatigability (only non-dominant hand) and with higher 
cognitive fatigability. Our findings support the theory behind the involvement of central factors 
for both fatigability and sleep quality and will provide the framework and basis for future 
research in this field. 
6.1.4. Chapter 5. Agreement between the NFI-MS and the MFIS 
The Modified Fatigue Impact Scale (MFIS) is a widely used measure of perceived fatigue in 
the MS population. It is also recommended for use by the Multiple Sclerosis Council for Clinical 
Practice Guidelines. The Neurological Fatigue Index (NFI-MS) have been recently validated for 
use as a measure for perceived fatigue in PwMS but is still not commonly used. Although the 
physical and cognitive domains of the two measures highly correlate with each other, the 
agreement between the two measures has never been explored before. The purpose of Chapter 5 
was to explore the agreement level between the physical domains of the MFIS and the NFI-MS, 
and the agreement level between the cognitive domains of the two measures.  
The Bland-Altman analysis revealed significant differences between both the physical and 
cognitive domains of the two measures, as well as significant proportional bias across the data 
points of the physical and cognitive domains. Our findings demonstrate that the MFIS and the 
NFI-MS cannot show a useful level of agreement in measuring physical and cognitive 
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perceptions of fatigue in our study sample. We argue, that perhaps the psychometric concerns 
regarding the MFIS and the difference in the number of items and scoring scales between the two 
measures may have contributed to the lack of agreement. Future studies are needed to verify 
these conclusions. 
6.2 Clinical Implications  
The findings of the current body of work have several interesting clinical implications. First, 
the NFI-MS is a validated, easy to administer, and easy to score scale that can be used more 
widely in clinical settings to measure perceptions of fatigue in different domains in PwMS. In 
addition, the physical measures utilized in this study to capture physical fatigability are already 
commonly used in clinical settings and can be easily modified by the clinician or therapist to 
capture physical fatigability. The CPT can be easily purchased and used as a measure of 
cognitive fatigability. The measures utilized in the current study can be used before and after 
treatment and rehabilitation interventions as outcome measures to explore the effect of different 
treatments on MS-related fatigue in PwMS. 
Despite our study participants being functionally independent individuals with active life 
styles, this sample had a significant detriment in physical and cognitive performance and high 
perceptions of fatigue that negatively affected their physical and mental quality of lives. This 
finding clearly shows the negative effect MS-related fatigue has on the functional quality of life 
of PwMS regardless of their functional independency and mild disease status. This was 
supported by the important finding in Chapter 2 in which higher perceived fatigue was 
significantly associated with a decreased physical quality of life. Those findings are clinically 
important, and clinicians and therapists may need to emphasize management and treatment 
options of MS-related fatigue in those with even less severe forms of MS. Despite those 
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individuals having independent, active lives, their fatigue can affect other important life indices: 
such as their interpersonal relationships, their sleep quality, and their mood and psychological 
well-being. Based on the findings of this study, we assume that perceived fatigue and fatigability 
would have a larger impact on those with severe forms with MS. Therefore, health care providers 
should also emphasize treatment and management options of MS-related fatigue in severe forms 
of MS to enhance the quality of life of those individuals. 
Our findings demonstrated the significant effect poor sleep quality has on MS-related 
fatigue. The results from Chapter 3 supports previous research that showed how self-reported 
poor sleep quality is associated with perceived fatigue in PwMS. Sleep disturbances are common 
in the MS population and have been shown to be associated with mood disturbances, reduced 
work load, and physical function in PwMS. We encourage a wider use of the NFI-MS especially 
because it is the only known scale to include sleep components that measure the effect of sleep 
quality on perceived fatigue in the MS population. Chapter 4 findings are novel in terms of the 
association between poor sleep quality and higher physical and cognitive fatigability. The 
fatigability measures utilized in this study resemble everyday life activities, and the finding that 
poor sleep quality may be a detriment to the performance of those tasks is clinically vital. 
Clinical settings should emphasize the need to assess sleep quality in PwMS and perhaps 
consider focusing part of their treatment plan to manage sleep disturbances that may contribute 
to the management of MS-related fatigue. It is important to note here that although we excluded 
those with untreated sleep disorders, it is possible that there were participants with an 
undiagnosed sleep disorder. The assessment of sleep disorders in the MS population is often 
overlooked by clinicians,100,101 and we encourage clinical settings to consider assessing for sleep 
disorders by referring their patients to sleep specialists. There is evidence that showed treating 
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sleep disorders decreased perceived fatigue in the MS population.121 Based on the findings of the 
current study, sleep quality seems to be an important clinical characteristic that is necessary to 
consider during the assessment and management of MS-related fatigue. 
6.3. Limitations 
The authors of this research acknowledge that although they attempted to avoid and 
minimize limitations where possible, some limitations are unavoidable with clinical research. 
Specific limitations are discussed in detail in individual chapters, but in this section we outline 
several broad limitations of the discussed chapters. 
6.3.1. Cross-sectional study design 
As with all cross-sectional study designs, we cannot interpret our findings into a cause-effect 
relationship. And gathering information at a single time point would prevent us from knowing if 
our findings would differ over time or in response to any external stimulus. Despite our attempt 
to schedule the participants on a similar time for the assessments, this was difficult to accomplish 
due to personal preference or due to work conflicts that made the time of the assessments 
variable across the participants. We tried to minimize the effect of those factors by instructing 
our participants to refrain from exercise 24 hours before the assessment day, and alcohol and 
caffeine consumption beyond usual intake at least 24 hours before assessment day. Furthermore, 
the temperature and humidity in the testing area were kept constant almost all the time (measured 
using a temperature/humidity sensor), and if any of the participants felt over-heated a fan was 
available to cool the participants. We believe for the purposes of our study, a cross-sectional 
study design was adequate to explore the associations between the outcome measures of interest.  
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6.3.2. Medication usage 
Prior to assessment, none of the participants were instructed to refrain from taking their 
usual fatigue and/or sleep related medications. In fact, we instructed the participants to continue 
using their usual medications and only avoid taking medications other than their typical ones. 
This might have affected their performance and response on the study measures. In addition, we 
attempted initially to collect current medication usage from all participants during the screening 
procedure. However, it was difficult to collect all the medication lists from all the participants as 
some forgot to bring the list on the day of the assessment and cannot remember all the 
medications they take, and due to difficulty contacting them after the assessments to gather this 
information. Therefore, there was not enough information regarding the sample’s medication 
usage to use for post-hoc analysis. However, we tried to explore their sleep quality and MS-
related fatigue without drastic changes to their usual medication usage. We believed it would be 
more difficult to interpret the findings if we asked the participants to stop their usual 
medications, because they will get back to their daily habits after the assessments and it will be 
hard to generalize our findings. Furthermore, the study has an important part of assessment 
which is the one week of actigraphy after the testing day. If the participants stopped their usual 
medications on the day of the study assessment, it will make more sense to ask them to stop their 
medications through the one week of actigraphy measure to accurately interpret the results. 
However, the authors believe that this is un-ethical to do and might have health consequences on 
the participants that would interfere significantly with the findings of the study.  
6.3.3. Study sample clinical characteristics 
The findings of the current research are not generalizable to individuals with MS with 
moderate to severe disease severity, as the study sample on average had mild disease severity 
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with mostly relapsing-remitting MS. The authors believe that some of the measures utilized in 
the study, specifically the physical and cognitive measures, would be difficult for those with 
more severe forms of MS to perform. Out of the 52 participants in the study, only five had 
secondary-progressive MS in which all were independent in mobility even with the use of an 
assistive device. Therefore, the findings of the study are well representable for only those PwMS 
who are functionally independent.  
In addition, pain has been found to exacerbate fatigue in the MS population.133,139 However, 
we did not collect or measure pain related information, which might have influenced the 
participants’ responses on our outcome measures. Another factor that may have influenced our 
findings is the possible presence of an undiagnosed sleep disorder. We tried to control for this 
factor by excluding those with known untreated sleep disorders, but with the current study 
procedures utilized we cannot control for those with an underdiagnoses of a sleep disorder. It is 
acknowledged in the literature that a high percentage of PwMS are undiagnosed with sleep 
disorders,100 which is an issue that needs serious attention from clinicians.  
6.3.4. Involvement of peripheral physical factors 
Performance on the physical fatigability measures utilized in the current study may have 
been influenced by peripheral factors.18,66,67 It will be difficult to conclude that our findings are 
purely the result of the dysfunction of the central motor networks. But it is believed that central 
factors appear to be the largest contributor to MS-related fatigue rather than peripheral 
ones.19,68,69,204 The involvement of peripheral factors might also be the reason why other studies 
that utilized similar physical fatigability measures did not find any association with perceived 
physical fatigue.57,60 However, the authors of the current research acknowledge that perceptions 
of fatigue and fatigability are two independent constructs of MS-related fatigue, and the lack of 
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association does not necessary mean a negative result. We believe that both constructs should be 
considered collectively for a more accurate comprehensive assessment of MS-related fatigue. 
6.3.5. Lack of correction for multiple comparisons 
Correction for multiple comparisons have not been made in the current study. However, the 
authors consider the current research exploratory due to the novel use of the NFI-MS as a 
measure of perceived fatigue to investigate its relationship with sleep quality and fatigability in 
PwMS. Furthermore, a larger sample size may reveal further significant results, but the required 
sample size was calculated during the study development, and enrollment was successfully 
achieved. Therefore, the authors are confident in the number of participants enrolled for every 
study chapter. 
6.4. Future directions 
Important implications for future studies can be derived from the experiments and findings 
conducted by this current body of work. The following section discusses the future directions 
that are relevant to the MS-related fatigue field of research. 
6.4.1. Investigating the effect of exercise interventions on perceived fatigue and fatigability in 
PwMS 
Different exercise interventions have been utilized before to explore their effect on 
perceived fatigue in PwMS.157,158,173,205 However, those studies had conflicting results: some 
found benefits of exercise on perceived fatigue, while others found no difference. To date, there 
is no consensus on what is the optimal type of exercise (aerobic, resistive, or combined) and 
intensity of exercise (moderate or vigorous) that decreases perceived fatigue in PwMS. 
Furthermore, none of those previous studies have utilized the NFI-MS before, and to our 
knowledge no previous study has explored the effect of exercise on fatigability in PwMS. 
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Therefore, it would be interesting to explore the effect of different modes of exercise on 
perceived fatigue and fatigability in PwMS. If found beneficial, exercise can be used as a non-
pharmacological treatment of MS-related fatigue and therefore lessen the side effects and the 
financial burden of the fatigue-related medications in PwMS. We recommend future studies to 
collectively use the NFI-MS and the fatigability measures used in the current study as outcome 
measures pre and post the exercise interventions.  
6.4.2. Assessing the relationship between sleep quality measured using Polysomnography and 
fatigability in PwMS 
Polysomnography (PSG) is the gold standard objective measure of sleep quality.111 The use 
of PSG can yield different sleep quality information compared to actigraphy (such as time spent 
in the different sleep stages), and can be used as a diagnostic tool for several sleep disorders. 
Few studies have explored the relationship between perceived fatigue and PSG.14,190,191 Those 
studies showed an association between higher perceived fatigue and sleep disorders and 
alterations in the sleep stages compared to healthy controls. None of the previously mentioned 
studies have used the NFI-MS as a measure of perceived fatigue. Perhaps future PSG studies 
might demonstrate different interesting findings with the use of the NFI-MS instead of the 
commonly used scales.  
Evidence demonstrates that the treatment of sleep disorders decreases perceived fatigue in 
PwMS.14,121 However, the relationship between sleep disorders and sleep quality measured using 
PSG and fatigability is unknown in PwMS. It is acknowledged in the literature that a high 
percentage of PwMS may have an undiagnosed sleep disorder.100 Future studies and even clinical 
and research settings should emphasize the need to assess for sleep disorders in the MS 
population. Based on the findings of Chapter 4, we assume that the presence of an untreated 
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sleep disorder would further increase fatigability. Future studies should perhaps investigate the 
effect of treating sleep disorders on fatigability in PwMS. Furthermore, poor sleep quality can 
occur even in the absence of a sleep disorder. Therefore, future studies can investigate the effect 
of non-pharmacological sleep-related treatment options, such as sleep hygiene educational 
programs that can indirectly affect fatigability through the improvement of sleep quality.  
6.4.3. Neural correlates with the NFI-MS and fatigability in PwMS 
Several neuroimaging studies70-73,206 have showed an association between perceived fatigue 
and several brain regions and microstructures in PwMS. However, none of those studies used the 
NFI-MS as a measure of perceived fatigue. Future neuroimaging studies might consider using 
the NFI-MS and explore its relationship with central regions. Perhaps because the NFI-MS is a 
more psychometrically sound scale than other scales, as different findings might be yielded.  
Nerve stimulation and transcranial magnetic stimulation (TMS) studies in healthy people 
have shown an association between physical fatigability and alterations in the excitability of the 
motor cortex and spinal cord.76,77 In addition, cortical alterations and dysfunction of the cognitive 
and motor planning networks that are associated with perceived fatigue in PwMS support the 
theory behind the involvement of central factors with fatigability.19 A combined assessment with 
magnetic resonance imaging (MRI) and transcranial magnetic stimulation (TMS) showed that 
perceived fatigue is associated with motor regions in the brain that are responsible for movement 
preparation, suggesting the possible involvement of physical fatigability in PwMS.204 The 
research on fatigability is still ongoing and we encourage future imaging studies to collectively 
measure MS-related fatigue using the NFI-MS and the fatigability measures utilized in the 
current research. For example, Diffusion Tensor Imaging (DTI)207 technique that is used to 
extensively characterize changes in white matter fiber tracts (such as demyelination), can be used 
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to explore the relationship between those microstructural changes and the NFI-MS and 
fatigability in PwMS. Exploring structural neural correlates with the NFI-MS and the fatigability 
would further support the central theory behind MS-related fatigue and lessens the ambiguity of 
this complex symptom. In addition, understanding the relationship between MS-related fatigue 
and the central nervous system can potentially guide clinical studies to develop more effective 
medications to manage MS-related fatigue. 
6.5. Conclusions  
In conclusion, the work presented in this dissertation expands on the body of evidence 
showing the relationship between perceived fatigue, fatigability, and sleep quality in PwMS. Our 
experiments and findings are novel and significant through the use of the NFI-MS as a measure of 
perceived fatigue and through the assessment of the association between sleep quality and 
fatigability in PwMS. The findings of this work demonstrate that perceived fatigue is associated 
with cognitive fatigability but not with physical fatigability in PwMS, and that decreased 
physical quality of life is a large contributor to perceived fatigue in PwMS with mild disease 
severity. Furthermore, higher perceived fatigue is significantly associated with poorer self-
reported sleep quality and excessive daytime sleepiness, but not with objectively assessed sleep 
quality. The presented work also provides the first evidence that poor sleep quality may 
contribute to fatigability in PwMS. More emphasis should be put on considering the role of sleep 
quality on exacerbating MS-related fatigue in those with the mild-disease forms of MS. Clinicians 
and therapists may need to consider sleep assessment and treatment as part of the MS-related 
fatigue management plan. Future studies can investigate the effect of different exercise 
interventions or sleep hygiene educational programs on MS-related fatigue using the outcome 
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